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Abstract. 
ATP binding cassette (ABC) transporters use ATP hydrolysis to facilitate the 
transfer of diverse substrates across the membrane.  Members of the methionine uptake 
transporter family, thought to be of considerable biological interest, have not been 
structurally characterized thus far.  The crystal structure of the methionine importer 
MetNI from Escherichia coli has been solved to 3.7 Å resolution.  The inward-facing 
conformation of this transporter adopts a more extreme arrangement than seen 
previously.  While the permease domain consists of just five transmembrane helices per 
monomer, the ATP-binding cassette domain possesses a C-terminal domain in addition 
to the conserved architecture shared amongst this family.  Analysis of the C-terminal 
extension has revealed a regulatory domain found in other proteins involved in amino 
acid metabolism, and further classifies this protein as part of the ACT family.  
Methionine binding in this region suggests a novel mechanism for regulation of 
transport that possibly stabilizes the inactive conformation of this family of 
transporters, as this domain is positioned between the nucleotide binding domains.  
Additionally, crystallization studies of the cognate binding protein to the MetNI system, 
MetQ were successful.  The structure of the MetQ binding protein from E. coli was 
solved to 1.8 Å resolution, revealing a bi-lobed structure consistent with many other 
substrate binding proteins, yet possessing a few differences when compared with 
previously characterized methionine binding proteins from other organisms.  The 
substrate binding pocket revealed a bound L-methionine residue, which shares key 
features with other methionine binding proteins and appears to be appropriately 
selective for L-methionine binding.  These combined studies have provided insight into 
the methionine uptake system and into the ABC transporter mechanism of transport. 
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Chapter One.  Introduction. 
1.1 Overview 
Cell membranes play a vital role in the survival of a cell in its role as a barrier.  
Proteins embedded within these membranes, however, are responsible for the more 
specific functions of a cell membrane, and typically account for 50% of the total 
membrane by weight (Alberts et al., 2002).  Transmembrane, or integral membrane 
proteins, are proteins that are able to traverse the membrane, possessing regions that 
are hydrophobic within the membrane and hydrophilic on either side of the membrane.  
Transport proteins, a class of membrane proteins, are responsible for the transfer of 
various molecules across the cell membrane.   
ATP Binding Cassette (ABC) transporters are integral membrane proteins that 
utilize ATP hydrolysis to facilitate the unidirectional transfer of diverse substrates across 
the periplasm (Figure 1.1).  Substrates for this family of transporters include amino 
acids, carbohydrates, metals, ions, lipids, drugs, toxins, peptides, osmolytes, 
siderophores, and vitamins (Higgins, 1992).  ABC importers assist in the uptake of 
nutrients and lipids after receiving the substrate from a substrate-specific binding 
protein within the periplasm.  These cognate binding proteins ensure substrate 
specificity and unidirectional transport of the transporter.  Exporters, however, are 
typically responsible for the excretion of drugs and toxins, and play a role in the 
presentation of antigens to cytotoxic T cells.  A rising number of medical conditions are 
linked to ABC transporter functions; the dysfunction of certain human ABC transporters 
leads to genetic diseases such as cystic fibrosis, while ABC exporters are responsible for 
multidrug resistance in tumor cells (Biemans-Oldehinkel, 2006).  In addition to 
multidrug resistance, ABC transporters play a role in a variety of human diseases, 
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ranging from immune deficiency to hypoglycemia, among others.  A study of the E. coli 
genome revealed that the ABC transporters are the largest family of paralogous 
proteins, comprising almost 5% of the E. coli genome (Hung et al., 1998; Higgins, 
2001).  This corresponds to approximately 70 different ABC transporters encoded by E. 
coli. 
  Architecturally, an ABC transporter comprises four domains (Figure 1.1): two 
cytoplasmic nucleotide binding domains (NBDs) responsible for hydrolyzing ATP, and 
two transmembrane domains (TMDs) that form a translocation pathway (Higgins, 
1992).  These can be encoded as 4 separate proteins, as a tetramer formed by 2 NBDs 
and 2 TMDs, by 2 half-transporters consisting of one chain that contains one TMD and 
cytoplasm 
periplasm 
exporter importer 
Figure 1.1. A conceptual diagram of ABC exporters and importers.  ABC importers interact with a 
substrate binding protein (in blue) that delivers the substrate (in black) to the transmembrane 
domain that forms the translocation pathway (in green).  Two molecules of ATP (in light blue) 
bind the ATPase domain (in purple) to provide the energy for transport of the substrate from the 
periplasm to the cytoplasm.  ABC exporters transport small molecules in the other direction, and 
are frequently a single chain or two chains of identical half-transporters, as opposed to the 
heterotetramer importer.  ABC exporter proteins bind ATP and have a similar ATPase domain to 
the importers, but both ABC exporters and importers have variable translocation domains 
specific to the substrate(s) being transported. 
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NBD, or alternatively by one long polypeptide chain encompassing all components 
(Higgins, 2001).  Transmembrane domains are structurally and sequentially diverse, 
containing between 8 and 20 core helices, thought to reflect the diversity of substrates 
transported, as these substrates bind within the translocation pathway.  The NBDs, 
however, possess certain sequence motifs.  The conservation of a ~215 residue core 
that comprises the NBD is important in the definition of this family.  The most 
characteristic features in the NBDs are the P- and Q-loops, present in many ATP-
binding proteins, and the ABC signature sequence, LSGGQ (Davidson and Chen, 2004).  
These conserved motifs, essential to ATP-binding and hydrolysis, suggest an archetypal 
mechanism for alternating between the inward- and outward-facing conformations 
required for substrate translocation. 
The first ATP-binding cassette structure was solved in 1998 (Figure 1.2).  This 
structure, of the E. coli histidine transporter (PDB ID: 1b0u), revealed the shared 
features present in this family of nucleotide binding domains (Hung et al., 1998).  The 
“phosphate binding loop”, or P-loop, common to other ATP binding proteins was 
identified in this protein as part of the ATP-binding pocket, and was found to 
correspond to the Walker A motif.  The P-loop was identified as wrapping around the 
β-phosphate of the ATP molecule, and provided hydrogen bonding for the hydrophilic 
regions of ATP as well as hydrophobic interaction with the adenine base.  The 
“signature sequence” of ABC transporters, a conserved segment containing the LSGGQ 
sequence, was also located in this structure as being important for transporter activity.  
Subsequent to this structure being solved, over two dozen other ATP binding cassette 
structures have been solved in the absence of the permease domain.  Perhaps the most 
well-characterized structure is that of the MalK dimer, which until recently was only 
characterized as a cassette and not a full transporter.  The MalK dimer has been 
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structurally characterized in multiple nucleotide-bound and nucleotide-free states 
within the reaction mechanism.  However, the transport mechanism is best understood 
with information from a combination of biochemical and structural studies; in that 
regard, a discussion of the full ABC transporter structures within the literature (as of 
March 2008) will be presented first.  
1.2 ABC Transporter Structures 
To date, there have been five distinct structures of ABC importer proteins 
published.  Additionally, there have been structural studies of two ABC exporters in 
various conformations.  The following is an attempt to summarize the findings of each 
Figure 1.2. The structure of the histidine ATP-binding subunit HisP (in purple), solved in 1998.  This 
was the first ATPase domain of an ABC transporter to be solved, and it was solved with a bound ATP 
molecule (in black).  This revealed many basic features of the ATP binding site that were later 
identified as being common to all ABC transporters. 
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of these novel structures and place them within a framework that illustrates the various 
conformations experienced during the transport process. 
The Vitamin B12 ABC Transporter 
The first structure of a complete ABC transporter was solved in 2002 by Locher 
et al. (2002).  This structure (PDB ID: 1l7v), of the vitamin B12 ABC transporter from E. 
coli, was solved to 3.2 Å resolution and revealed an interesting conformation of the four 
subunits (Figure 1.3).  In this structure, the two ATPase subunits are in close contact to 
one another, and many features on the individual BtuD subunit resemble those found in 
 
Figure 1.3. The structure of the first complete ABC transporter, the vitamin B-12 transporter from E. 
coli.  This structure, published in 2002, is representative of an outward-facing conformation, as 
indicated by the positions of the two transmembrane domains (pink and green) and their relative 
positions to the two ATPase domains (tan and purple), despite a lack of bound nucleotide. 
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HisP.  Interestingly, there is no nucleotide bound.  As with other published ATP binding 
cassette structures, BtuD consists of a six-stranded β-sheet surrounded by nine α-
helices and a smaller β-sheet made up of 3 β-strands.  The dimer, as with other ATP 
binding cassette dimers, shows the cassettes aligned in such a way that they are 
opposite one another in a head-to-tail fashion.  Two ATP binding sites are created in the 
clefts between the P-loop and signature motifs of different subunits.  Most of the 
interface between these two identical subunits is formed by highly conserved residues, 
frequently those that are part of the important sequence motifs for this family.  
Conversely, the novel (at the time) transmembrane region consists of ten helices per 
monomer; each monomer is also in close contact with its counterpart.  The 
translocation pathway formed by these two transmembrane domains is closed to the 
cytoplasm, open to the periplasm, and is lined with hydrophobic residues.  Another 
interesting feature revealed by this structure concerns the interface between the 
transmembrane subunit and the ATPase domain.  There is a cytoplasmic loop between 
TM6 and TM7 within the BtuC transmembrane domain that folds into two short helices 
that each have significant contacts with the BtuD ATPase domain.  Further sequence 
analysis revealed that this sequence is well conserved amongst ABC transporters, and 
was further named the “EAA” loop (Saurin et al., 1994).  On the ATPase domain, 
residues from the Q-loop are responsible for contacts with the transmembrane domain.  
Overall, this structure was a critical turning point in the study of ABC importers, as the 
techniques used in this structure were useful in the preparation and study of other ABC 
transporters (Locher, 2004). 
The story of BtuCD does not end with this one structure.  Attempts to crystallize 
the complex of BtuCD along with the E. coli vitamin B12 binding protein BtuF proved 
ultimately successful, as reported by Hvorup et al., in 2007 (Figure 1.4).  The 2.6 Å 
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resolution structure of the BtuCD transporter (PDB ID: 2qi9) in complex with its 
binding protein possesses features not found in the individual structures, and was able 
to shed light on the process of how this complex is formed.  In this structure, vitamin 
B12 is not present, and the vitamin B12 binding protein BtuF, a bi-lobed structure, has its 
lobes spread further apart than in the vitamin B12 structures previously solved 
(Karpowich et al., 2003).  Furthermore, the structure of BtuCD in this complex differs 
from the previously characterized structure.  The transporter is closed to both the 
cytoplasm and the periplasm, and the two monomers of BtuC, the transmembrane  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. The structure of the BtuCD-BtuF complex is shown above.  This unusual structure 
revealed another conformation of the BtuCD transporter, despite nucleotide or substrate binding.  
This structure suggests that it is possible for the translocation pathway to be closed to both the 
cytoplasm and the periplasm in the absence of nucleotide and substrate. 
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domain, are in slightly different conformations.  The two-fold symmetry present in the 
first BtuCD structure is not present, and this asymmetry is most striking on the 
cytoplasmic-facing portion of the membrane spanning subunit.  The interface of BtuC 
and BtuF confirms previous predictions (Borths et al., 2002) that salt bridges between 
oppositely charged residues play an important role in the attraction between these two 
proteins.  Loops from BtuC insert into the BtuF structure, possibly forcing the substrate 
into the translocation path.  The nucleotide binding domains are in a nucleotide-free 
open state, but each individual subunit is structurally similar to the previously studied 
form.  The changes between these two structures are a result of a flexible movement of 
the two BtuD monomers relative to one another, not within each monomer.  As a result, 
the authors believe this structure is reflective of the transporter in a post-translocation 
stage in the transport mechanism.  To further confirm their observations, they pursued 
a spin-labeling study that allowed them to replace all native cysteines with serine 
residues, and engineered specific cysteine residues within the TM5 helix in BtuC to use 
in spin labeling.  The spin-labeled cysteines were studied using continuous wave EPR 
spectra to monitor the environment of the label; studies showed that BtuCD had 
considerably more flexibility in this region than the BtuCD-BtuF complex.  Other spin-
labeling studies further supported the structural observations, suggesting that this in 
fact was a rigid, asymmetric conformation of the BtuCD-BtuF complex. 
A Metal-Chelate Type Transporter 
The highest resolution ABC transporter structure solved thus far is the putative 
metal-chelate type transporter HI1470/1 (Pinkett et al., 2007).  This 2.4 Å resolution 
structure (PDB ID: 2nq2) is homologous to the BtuCD structure, as it possesses similar 
ATPase domains and membrane-spanning subunits that contain ten transmembrane 
helices per monomer (Figure 1.5).  However, this structure revealed an inward-facing 
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conformation as compared to the outward-facing conformation of BtuCD, despite the 
fact that both structures are nucleotide-free.  The relatively small movements illustrated 
between these two structures are interesting, as the difference between the inward- and 
outward-facing conformations of these homologs appears to be accomplished with 
slight shifts in the transmembrane domains.  More specifically, the transmembrane 
domains must undergo a translational movement in the plane of the membrane to shift 
between these two states.  This difference causes the HI1470/1 structure to be closed to 
the periplasm, while the BtuCD structure is more open to the periplasm.  Similarly, the 
nucleotide binding domains of these two structures exhibit a slight difference; the 
Figure 1.5. The structure of the metal-chelate type transporter HI1470/1.  This transporter, a 
homolog of BtuCD, was found to be in the inward-facing conformation, with key differences in 
the placement of helices in the transmembrane domain (pink and green) and in the relative 
orientation of the two ATPase units (tan and purple). 
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HI1470 dimer has a slightly more open conformation than the BtuD dimer.  A 
comparison of these two structures has highlighted certain structural elements that 
may be important in substrate translocation, ATP binding and hydrolysis, as well as the 
movement that occurs in both of these domains during the substrate translocation 
process.   
The Molybdate Transporter 
The first structure of an ABC transporter in complex with its binding protein 
was the structure of the molybdate transporter ModBC (Hollenstein et al., 2007).  This 
Figure 1.6. The structure of the ModA-ModBC complex.  This interesting structure revealed a novel 
transmembrane domain consisting of only six transmembrane helices (pink and green) as well as a 
new relative orientation of the ATPase subunits that were further apart than other structures.  
Additionally, the interface of this transporter with its cognate binding protein provides insight on the 
complex formation needed for transport. 
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3.1 Å resolution structure (PDB ID: 2onk) reveals a nucleotide-free, open conformation 
within the nucleotide binding domains ModC (Figure 1.6).  The membrane-spanning 
domain, ModB, revealed a novel, considerably smaller set of six helices per monomer 
that shape the inward-facing conformation.  Interestingly, one helix in each monomer 
crosses over to interact with the helices of the opposing monomer.  In contrast to other 
structures of the transporter-binding protein complex, the binding protein in this 
structure contains a bound substrate, and is in a closed form; the overall structure of 
this complex indicates it is in a conformation that precedes transport.  The substrate 
binding pocket of the binding protein is aligned with the translocation pathway, 
suggesting that ATP binding is necessary to promote active transport.  Small helical 
regions (“coupling helices”) on a loop from the transmembrane domain mitigate 
movement between the nucleotide binding domain and the transmembrane domain, as 
seen in other structures.  This region contains the conserved “EAA” motif and is thought 
to play an important role in communicating movement between the nucleotide binding 
domain and the transmembrane subunit.  This structure fortifies the hypothesis that 
each cycle of transport translocates one substrate molecule across the membrane, yet 
requires two ATP molecules, suggesting a stoichiometrical relationship of 1 substrate to 
two ATP molecules.  Mechanistic analysis suggests that transporters share a common 
“alternating access and release” mechanism as they move between the inward-and 
outward-facing conformations as a result of binding protein docking, substrate 
binding, ATP binding, and subsequent ATP hydrolysis. 
The Maltose Transporter 
Most recently, the structure of the full maltose transporter in complex with the 
maltose binding protein and the maltose substrate was solved to 2.8 Å resolution 
(Oldham et al., 2007).  This fascinating structure (PDB ID: 2r6g) is perhaps the most  
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unusual of all ABC transporter structures, as it shows the maltose ligand within the 
translocation pathway, an observation heretofore unseen (Figure 1.7).  The ATP-bound 
Figure 1.7. The structure of the complete maltose transporter, MalFGK, in complex with the maltose 
binding protein.  This fascinating structure revealed the first substrate binding site within a 
translocation pathway, and provided considerable insight into the ability of the transmembrane 
domain (pink and green) to interact with the binding protein (blue) and encourage substrate release 
into the translocation pathway.  Additionally, the ATPase subunits are closely intertwined in this ATP-
bound state, while this structure reveals the first structure with structurally and sequentially unique 
transmembrane units (MalF in green, MalG in pink).  These two subunits, while quite different in 
length, share a common core of 6 helices that forms the translocation pathway. 
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structure was obtained using a mutation in the Walker B region that prevents ATP 
hydrolysis, thereby trapping the transporter in a “closed” state.  The MalFGK2 structure 
revealed the first ABC transporter with two different transmembrane domains 
comprising the translocation pathway.  MalF and MalG share a common core of six 
helices, in an arrangement very similar to that of the ModBC structure; in this 
arrangement, one helix from each subunit crosses over and interacts with the opposite 
subunit.  However, MalG and MalF share only 13% sequence identity, and the much 
longer MalF possesses a C-terminal segment that packs against the MalK subunit and is 
not present in MalG.  The interface between the two transmembrane domains and 
MalK also shares similarities to the other published structures.  The “EAA”, 
“EAAXXXG”, or “coupling helix” loop, as it has been named, is responsible for the 
majority of the interaction between the transmembrane domains and the ATPase units.  
Furthermore, it was established that the glutamate residue present in this loop forms a 
salt bridge with a highly conserved arginine residue.  In the translocation pathway, 
maltose binding was stabilized by nearby residues.  The sugar rings were packed 
against Tyr383 and Phr436 from MalF, while hydrogen bonding interactions with the 
maltose ligand are made by Tyr325, Ser329, Asn376, Gly380, Ser433, Asn437, and 
Asn440, all from MalF.  MalG, interestingly, did not contact the maltose ligand.  As the 
maltose ligand was found bound to the MalF maltose binding site, the maltose binding 
protein was in an open form.  Similar to the BtuCD-F structure, the two lobes of the 
maltose binding protein were pried open, and a loop from the MalG protein named the 
“scoop” entered the maltose binding site, enabling its movement from the maltose 
binding site on the maltose binding protein into the MalF binding site within the 
transporter translocation pathway.  This structure has many interesting features, and  
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represents the transition state of ligand transport much better than any previously 
published structure, providing a look at the ability of the translocation pathway to bind 
and transport this carbohydrate ligand. 
ABC Exporters 
Structural studies of certain ABC exporters have also been pursued; while these 
exporters have significant differences from ABC importers, there are common features 
between these two groups.  Perhaps the most striking similarity is between exporter and  
Figure 1.8. The structure of the multidrug exporter SAV1866 from S. aureus.  The complete 
structure is composed of two half-transporters (pink and green) that each possess a transmembrane 
domain and an ATPase domain.  The two half-transporters are considerably intertwined in this 
conformation, though no nucleotide was bound. 
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importer ATP binding cassette domains, which possess conserved structural 
characteristics.  The crystal structure of SAV1866, a multidrug exporter from 
Staphylococcus aureus, was solved by Dawson and Locher (2006) to 3.0 Å resolution, 
and shortly afterwards, a structure with bound AMP-PNP was solved to 3.4 Å resolution 
(Dawson and Locher, 2007). The structure of SAV1866 (PDB ID: 2hyd and 2onj) 
reveals two half-transporters that are intertwined to make up the active transporter.  
Each half-transporter consists of a transmembrane (N-terminal) domain and a 
nucleotide binding (C-terminal) domain, and are twisted around each other in the 
structure (Figure 1.8).  Each transmembrane domain crosses the membrane lipid 
bilayer six times, resulting in a total of 12 TM helices for the full transporter.  The NBD 
contains the typical ATP-binding cassette motifs and closely resembles the previously 
published structure of MJ0796 (Smith et al., 2002).  While ADP is bound in the ATP 
binding cassette of SAV1866, Dawson and Locher have hypothesized that the 
transporter is actually in the ATP bound state, based on the tight binding of the 
nucleotide and a comparison to the previously published structure of BtuCD.  In this 
structure, it is apparent that there are a few loops in the TMD that allow 
communication between the NBD and TMD.  These loops (which actually have helical 
regions) are named “coupling helices”, to refer to the fact that they couple the 
movement of these two domains, depending on the presence of ATP and a substrate.  
Interestingly, the structure shows that there is a crossing-over that occurs within these 
helices, as one helix interfaces with the adjacent NBD, while the other interfaces with 
the opposite NBD.  This arrangement also suggests that the nucleotide binding domains 
are not able to move far apart from one another, as is seen in MsbA (see below) and 
certain importers.  The mechanism of transport suggested by Dawson and Locher 
involves two states of the transporter: an inward-facing conformation with interior 
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access to the substrate binding domain, and an outward-facing conformation with 
external access to release the unwanted substrate.  SAV1866 is hypothesized to be in 
the ATP-bound, outward-facing state, where the substrates would be released into the 
lipid bilayer or the surrounding medium.  The hydrolysis of ATP would convert the 
transporter back to its inward-facing conformation, in what Dawson and Locher have 
described as an “alternating access and release” mechanism.  In addition to the 
SAV1866 multidrug exporter, structures in various conformations of the lipid flippase 
MsbA from three different organisms (E. coli, V. cholerae, and S. typhimurium) have 
been published (Ward et al., 2007).  These structures (PDB ID: 3b60, 3b5w, 3b5x, 
3b5y, 3b5z) also possess the characteristic ATPase domain and show different states of 
homologous transporters, despite the controversy associated with the original crystal 
structure analyses of these structures.  
1.3 The Catalytic Cycle of ABC Transporters 
Attempts to understand the catalytic cycle of ABC transporters have been 
underway for many years.  It has been shown that both NBDs are required for transport 
and that one ATP binds to both domains of the dimer, suggesting that these two sites are 
coupled (al-Shawi et al., 1994; Loo and Charles, 1995).  As the NBDs can dimerize and 
hydrolyze ATP in solution, crystallization studies of native ATP-bound NBDs has proved 
difficult.  However, certain mutations abrogating ATP hydrolysis have enabled the study 
of ATP bound structures, such as the MJ0796 cassette (Smith et al., 2002).  The ATP 
molecule is substantially bound by the NBD core: the Walker A and B motifs, as well as 
residues providing a π-stacking interaction with the adenine ring play an important 
role in this binding.  Additionally, a histidine that is part of the His-loop contacts the 
nucleotide, the Q-loop interacts with the γ-phosphate of ATP through a water molecule,  
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and the ABC signature loop stabilizes the ATP molecule bound to the P-loop of the 
opposing NBD.  Similarly, many NBDs do not form dimers in the absence of nucleotide.  
MalK is the exception to this, as it does form a dimer without nucleotide present, 
presumably due to the C-terminal extension beyond the homologous NBD region that is 
thought to be a regulatory domain.  Intact transporters appear to be more stable in the 
absence of nucleotide, perhaps due to the TMDs, as evidenced by the number of 
nucleotide-free transporter structures.  The study of the MalK dimers in various 
conformations (PDB ID: 1q12, 1q1b, 2awo) revealed a tweezer-like motion between 
the two dimers upon ATP binding (Davidson and Chen, 2004).  The C-terminal 
“regulatory domain” remains in contact regardless of the nucleotide present, but the 
homologous nucleotide binding domain experiences considerable changes (Figure 1.9). 
Figure 1.9. A comparison of two conformations of the MalK dimer.  The overlay of one subunit 
(shown in tan) allows the differences in the relative placement of the opposing subunit (ATP-
bound state in green, non-nucleotide form in pink) to be highlighted.  The ATP-bound 
conformation clearly has the two ATPase subunits much closer together compared with the apo 
dimer. 
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A common mechanism has been proposed for both ABC importers and 
exporters.  It has recently been suggested that the binding of ATP promotes the 
outward-facing conformation, while the production and release of ADP and phosphate 
stabilizes the inward-facing conformation (Dawson and Locher, 2007). In most 
descriptions of the catalytic cycle, the P-loop and ABC signature motif are deemed 
important for interactions with ATP, while the Q-loops are important for the NBD-
TMD interface.  The “head-to-tail” arrangement of its NBD dimer is a critical element 
of ABC transporters, as this organization forces the opposing dimers to form two 
nucleotide binding sites using the conserved sequence motifs.  The P-loop of one NBD 
forms a nucleotide binding site with the ABC signature motif from the opposite NBD, a 
concept first identified with the structure of the Rad50 protein (Hopfner et al., 2000).  
Nucleotide-free structures impose fewer constraints on the structure, as evidenced by 
the variations observed between nucleotide-free structures; the various conformations 
of these transporters have been classified in “open” or “closed” states.  The “coupling  
 
 
 
 
 
 
 
 
Figure 1.10. A conceptual diagram of the “closing” motion of nucleotide binding domains that 
occurs with ATP binding (ATP is represented in dark blue).  This “closing” results in a shift 
towards the translocation pathway of the coupling helices of the transmembrane domain (in 
pink and green); this narrowing prepares the translocation pathway for substrate transport, 
pushing the transporter from an inward-facing to an outward-facing conformation. 
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cytoplasm 
periplasm 
resting state transition state 
Figure 1.11. A schematic of the suggested mechanism of an ABC importer.  In the resting state, the 
inward-facing transporter can bind ATP (pink spheres).  ATP binding leads to complex formation 
with a substrate binding protein (blue) that has substrate bound (black sphere).  As the substrate 
binding protein delivers the substrate to the transporter, the transporter shifts to the outward-facing 
conformation (in the transition state) and the substrate travels through the transmembrane domain, 
leading to release of the substrate and ADP (blue spheres) and Pi (gray spheres) into the cytoplasm.  
The transporter then returns to the resting state awaiting the next cycle of ATP binding. 
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helices”, described as the important part of the TMD and its interface with the NBD, 
comprise the key shared feature amongst transmembrane regions.  Movement of these 
helices towards or away from the translocation pathway appears to be important for 
the transmission of information between these two domains (Figure 1.10).  Mutations 
in this area result in a decrease in transport or no transport at all (Hollenstein et al., 
2007). 
The full catalytic cycle may be summarized through a few different states (Figure 
1.11).  In the “open” state, NBDs are apart.  Examples of this state include the ModBC-
ModA or HI1470/1 structures.  Once ATP binding occurs, the transporter can shift into 
a “closed” conformation, where the ATP is bound tightly between the NBD motifs 
previously mentioned, such as the P-loop and the ABC signature loop.  Examples of an 
ATP-bound structure would include the MalFGK2 structure, as well as the SAV1866 
exporter structure.  In addition to the movement of NBDs, a key difference between 
these two conformations is the movement of the “coupling helices” and the subsequent 
shift of transmembrane helices.  In moving from the “open” to “closed” states, the 
transmembrane helices shift towards each other.  Once hydrolysis of ATP occurs, the 
transporter shifts back to the “open” conformation, its resting state.  The stoichiometry 
of transport has been established; studies of glycine transporter OpuA (Patzlaff et al., 
2003) as well as studies of the maltose transporter MalK have revealed that there 
appear to be two ATP molecules required per one molecule of substrate transported 
(Dawson and Locher, 2007).  Overall, this mechanism corresponds to the “alternating 
access and release” mechanism first postulated by Jardetzky in 1966. 
1.4 Regulatory Mechanisms: The ACT Domain 
The regulation of many ABC transporters can occur at the gene level.  However, 
ABC transporters often possess C-terminal domains connected to the nucleotide binding 
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domains that are proposed to function as regulatory domains (Biemans-Oldehinkel, 
2006).  These “autoregulatory” domains are present in a variety of ABC transporters: 
MalK, OpuA, CFTR, and others.  Each of these domains, however, is hypothesized to act 
in different ways.  One such mechanism predicted to be important for some amino acid 
ABC transporters is the ACT domain. 
The ACT domain, initially identified by Aravind and Koonin (1999), is a novel 
ligand-binding domain based upon a similarity in three different structures: 
aspartokinase, chorismate mutase, and TyrA (ACT).  This shared domain of unknown 
function was identified in aspartokinases, chorismate mutases, prephenate 
dehydrogenases, prephenate dehydratases, homoserine dehydrogenases, malate 
dehydrogenases, phosphoglyerate dehydrogenases, phenylalanine and tryptophan-4-
monooxygenases, phosphoribosylformylglycinamidine synthase, uridylyl transferase 
and removing enzyme, GTP pyrophosphokinase/phosphohydrolase, tyrosine and 
phenol metabolism operon regulators,  as well as several uncharacterized proteins from 
archaea, bacteria, and plants that contain from one to four copies of this domain 
(Aravind and Koonin, 1999).  Luckily, some of these proteins had been structurally  
 
 
Figure 1.12. Two views of the ferredoxin-like domain that make up each monomer of the ACT 
domain.  Four β-strands make up an antiparallel β-sheet, with two α-helices covering one face of the 
strand.  This domain dimerizes to form the complete ACT domain. 
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characterized, allowing a further analysis of this domain.  The structure of 3-
phosphoglycerate dehydrogenase (PDBID: 1psd) revealed this domain to be the C- 
terminal regulatory domain of 70-80 amino acids that formed a β-sheet with strand 
order 4-1-3-2 surrounded by helices (Figure 1.12).  Upon further analysis, this domain 
was identified as having the ferredoxin-like fold, according to SCOP.  A ferredoxin-like 
fold is defined as having the βαββαβ topology (Chipman and Shaanan, 2001).  In the  
structure of 3-phosphoglycerate dehydrogenase, this domain binds L-serine, the final 
product of this biosynthetic pathway, and an allosteric regulator of this enzyme.  The 
ACT domain is thought to possess a common ligand-binding area, critical to the 
function of this fold in regulation; many of the enzymes possessing this domain are 
known as “classic” allosteric regulators.  Further analysis of this domain revealed that 
this domain forms a dimer, resulting in an 8-stranded β-sheet, with 2 ligand molecules 
Figure 1.13. The ACT domain of 3-phosphoglycerate dehydrogenase.  The two ferredoxin-like 
domains form an 8-stranded β-sheet capped by 4 α-helices.  The two serine molecules (in blue) 
bind at the interface of these two domains; this binding site is shared amongst other ligands 
utilizing this domain. 
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bound at the interface, suggesting that this is a conserved regulatory fold.  While 
certain ACT family members show sequence homology, others have more divergent 
sequences while maintaining the same topology and ligand binding site (Chipman and 
Shaanan, 2001).  A study of the types of proteins possessing ACT domains revealed that 
the majority of these are involved in amino acid and purine biosynthesis, and were 
previously known to be allosterically regulated proteins (Liberles et al., 2005).  While 
the mechanism of action of this domain is not fully understood, it has been suggested 
that ligand binding leads to low flexibility within this domain and the rest of the 
structure, as rotations to allow for normal activity are blocked (Grant, 2006).  As ACT 
domains have been identified in Archea, Bacteria, and Eukarya, they have been 
described as a “conserved, evolutionarily mobile module that, when fused to other 
proteins, makes them susceptible to regulation by small molecules” that probably 
appeared early on in the evolutionary process (Grant, 2006). 
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Chapter Two. MetNI. 
2.1 Introduction 
The high-affinity methionine transport system MetD of E. coli consists of MetN, 
the ATPase domain, MetI, the transmembrane domain, and MetQ, the cognate binding 
protein located in the periplasm.  The progression of study that resulted in the 
identification and characterization of MetD dates back to the mid-1950s, when amino 
acid transport in bacteria became a significant topic of research.  While the methionine 
transporter was first partially described by Piperno and Oxender in 1968, numerous 
studies in the 1970s by Robert Kadner characterized the methionine uptake system in E. 
coli.   A study by Kaback et al. (1970) suggested that methionine uptake (among other 
amino acids) was enhanced by the presence of D-(-)-lactate, although membrane 
vesicles were unable to accumulate methionine, forging questions in the minds of these 
researchers about what type of transport systems brought methionine into the cell, and 
whether these transport systems utilized a binding protein and/or ATP, or were able to 
directly derive energy from some portion of the electron transport chain (Kadner, 
1974).  Other amino acids were thought to be transported into the cell via multiple 
mechanisms, some of which employed a binding protein and ATP, while others directly 
utilized energy from the electron transport chain, as described by Lombardi and Kaback 
(1972).  Kadner, however, set out to provide a more complete characterization of the 
methionine uptake system.  Interestingly, Kadner also was responsible for initial 
characterization of the BtuCD Vitamin B12 ABC transporter system (Kadner and 
Watson, 1974), a connection that was derived from the biosynthesis-related ties 
between these two nutrients established by Davis and Solowey (1950). 
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The first studies by Kadner on this system described a temperature-dependent 
methionine uptake system that allowed for the accumulation of methionine (Figure 2.1) 
against a gradient.  Kadner (1974) reported that the internal pool of methionine is 
estimated to be 0.1-0.3 mM, as the vast majority of intracellular methionine is 
converted to other metabolites such as spermine and spermidine within five minutes 
after uptake.  Kadner suggested that this uptake was somehow dependent on energy, 
but was unsure whether this energy source came from glycolysis or oxidative 
phosphorylation.  He was further able to identify two separate methionine transport 
systems: a high-affinity system (with a Kt of approximately 7.5 x 10-8 M) and a low-
affinity system (with a Kt of approximately 40 x 10-6 M) that differed over 400-fold in 
their ability to transport L-methionine.  In his initial characterization, he was also able 
to identify certain methionine derivatives or dipeptides that acted as inhibitors to the 
methionine uptake system, and to determine that D-methionine, ethionine, and other 
Figure 2.1.  Above is the structure of the amino acid L-methionine, in both chemical (left) 
and 3-dimensional (right) forms.  It is this amino acid that is being transported by the MetNI 
transport system. 
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amino acids had low inhibitory activity.  However, further studies began to slightly 
contradict his initial paper.  Later the same year, he published a paper (Kadner and 
Watson, 1974) further describing the two uptake systems for methionine, named MetD 
and MetP.  These studies suggested that the higher-affinity system, MetD, was in fact 
able to transport D-methionine as well as L-selenomethionine.  Kadner went on to 
study and better understand the MetD and MetP mutants and the effects of these 
mutants on methionine activity; mutants of MetD lack high-affinity transport for L-
methionine and low-affinity uptake for D-methionine (Kadner, 1977). 
As Kadner progressed in his study of the methionine uptake system, he 
encountered a mechanism of regulation in E. coli.  In 1975, Kadner described that the 
activity of the methionine uptake transporter is regulated by the concentration of the 
internal methionine pool.  He found that the activity of the transporter is depressed 
when cells are grown in the presence of methionine, but not methionine mimetics such 
as α-keto-γ-methiol-butyrate, D-methionine, or methionine sulfoxide.  His research 
additionally suggested that this transport system was regulated by gene repression.  
Studies of the MetD system by Kadner revealed that D-methionine was a useful 
methionine source for E. coli and was transported by the MetD system (Kadner, 1977).  
He further hypothesized that there were two substrate binding domains within the 
MetD system for both stereoisomers.  Energetics studies suggested that transport was 
driven by phosphate bond energy (Kadner, 1975), but the use of ATP was not 
confirmed conclusively until another study.  Another paper published in 1975 provided 
further evidence that the source of metabolic energy that allowed the transport of 
methionine was in fact ATP.  The transport of methionine was found to be sensitive to 
arsenate but mostly insensitive to azide or dinitrophenol.  Furthermore, adenosine 
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triphosphatase mutants were created that affected transport and supported the idea that 
methionine transport utilizes ATP (Kadner and Winkler, 1975). 
It was not until 2002 that the genes for the MetD system were identified and 
described as possibly comprising an ABC transporter (Merlin et al., 2002).  Within the 
gene locus initially identified by Kadner, Merlin et al. were able to find six genes, of 
which four were unidentified and two (Abc and YaeE) were thought to be an ABC 
transporter ATPase and an ABC transporter permease, respectively.  These two genes, 
Abc and YaeE, were labeled as an ABC transporter due to sequence homology, 
particularly the Abc protein that contained many ABC transporter sequence motifs.  The 
permease, YaeE, was hypothesized to possess five transmembrane helices.  Further 
analysis using the BLAST tool identified YaeC as a possible methionine binding protein; 
the three genes were subsequently renamed to MetN, MetI, and MetQ to represent the 
ATPase, transmembrane domain, and binding protein, respectively.  Merlin et al. also 
studied the genetic organization of the MetD locus within a variety of other sequenced 
bacteria.  A similar organization was found in S. typhimurium, S. typhi, Y. pestis, V. 
cholerae, P. multocida, H. influenzae, A. tumefaciens, S. meliloti, B. melitensis, and M. 
loti, suggesting that each of these organisms has a similar methionine uptake system.  
Their studies described MetD deletants that were able to grow on a media 
supplemented with L-methionine (due to uptake from the MetP system) but were 
unable to grow on a media supplemented with D-methionine as its sole methionine 
source.  Furthermore, the MetJ repressor acts as a regulator of the three metD genes at 
the genetic level, as shown by both Merlin et al. (2002) and Gál et al. (2002).  Efforts to 
identify genes encoding other methionine uptake system, MetP, have thus far not been 
successful.  
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Building further on the concept that a similar organization for this gene is 
present in multiple organisms, Zhang et al. (2003) redefined this system as a 
methionine uptake transporter (MUT).  Their phylogenetic analysis revealed that this 
methionine uptake system was present in multiple organisms in the form of sequence-
divergent primordial paralogs.  These proteins make up the methionine uptake 
transporter family, one of the first functionally characterized novel families of bacterial 
ABC permeases.  An analysis of MetD mutations in S. typhimurium led to the mapping 
of the MetD gene near 4.8 minutes on the E .coli genome, which coincides with an ABC 
transporter mapping (Zhang et al., 2003).  Regulation by these genes and other 
methionine biosynthetic genes by the MetJ repressor has been established (Weissbach 
and Brot, 1991; Greene and Spiegelman, 1996; Sekowsha et al., 2000), along with a 
MetJ DNA binding site consensus sequence (Saint-Girons et al., 1984) and the 
identification of a MetJ binding site in the promoter region of the MetD ABC 
transporter locus (Liu et al., 2001).  Homologues of each of the three proteins within 
the MUT family share a similar size, and the transmembrane regions for all of them are 
hypothesized to have five transmembrane segments.  The relationships revealed in the 
phylogenetic analysis suggest that these genetic duplications occurred early during 
evolutionary history, as the topology of the phylogenetic trees does not follow the 
phylogenies of these organisms.  It has been hypothesized that there were several 
sequence-divergent primordial paralogs, which would account for the topology seen. 
Zhang et al. (2003) went on to reveal that both L-methionine and D-methionine 
were transported by the MetD transporter system.  Studies using radiolabeled (14C) L- 
and D-methionine showed that both L- and D-methionine were substrates of the same 
MetD transporter system.  Inhibition studies confirmed previous studies on this subject; 
while other amino acids were not inhibitors, N-formyl L-methionine was.  
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Furthermore, the use of energy poisons such as sodium arsenate abolished uptake of 
methionine, while others were less effective, suggesting that ATP is in fact the energy 
source for transport, as believed.   
Studies have also elucidated possible pharmaceutical interest in this family of 
transporters, as several members of the MUT family are required for bacterial 
pathogenicity.  It has been found that the MUT family member of S. typhimurium is 
essential for infection in mouse models (Pattery et al., 1999).  A mutation in the MUT in 
the organism H. influenzae leads to reduced infection in rats (Chanyangam et al., 
1991).  The H. pylori MUT plays a role in the production of urease, which is essential 
for colonization of this organism (Hendricks and Mobley, 1997).  Strains of Y. pestis 
frequently depend upon exogenous methionine for survival, and may also make MUTs 
important in this organism (Brubaker, 1972).  The importance of this family of 
transporters is not fully understood, but the implications within the pharmaceutical 
field are clearly growing, necessitating further study of this system. 
To further investigate this system, we have determined the structure of the E. 
coli methionine ABC transporter MetNI following overexpression and affinity 
purification with dodecyl maltoside.  
2.2 Structure of the MetNI Transporter 
Crystallographic analysis revealed a nucleotide-free state (Figure 2.2 and Figure 
2.3) that was refined to 3.7 Å after phasing with single isomorphous replacement and 
anomalous scattering from a xenon derivative (Figure 2.4).  The sequence register was 
verified with a difference Fourier density map from data collected on 
selenomethionine-substituted crystals, which identified 34 selenomethionine sites, as 
well as improved maps generated from solvent flattening and non-crystallographic 
symmetry averaging.  
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The overall architecture of MetNI reveals two copies of the ATPase MetN in 
complex with two copies of the transmembrane domain MetI.  The methionine 
transporter has a smaller transmembrane domain than other published ABC transporter 
structures, consisting of only five transmembrane helices per monomer.  The 
cytoplasmic ATPase contains the expected conserved ABC region, but possesses a C-
terminal extension of approximately 100 amino acids that comprises an ACT regulatory 
domain that has not been seen previously as part of an ABC transporter.  The relative 
positions of the two ATPase subunits and their corresponding transmembrane domains 
illustrate a distinct inward-facing orientation.  Additionally, each of the two copies of 
MetN in the transporter adopts slightly different conformations, resulting in an 
asymmetrical organization of the MetN dimer due to a proposed hinge between the 
conserved ABC region and the C-terminal domain.   
Analysis of this crystal form established the presence of two transporters in the 
asymmetric unit (Figure 2.5).  Interestingly, these two transporters are in slightly 
different conformations, with one heterotetramer in a slightly more inward-facing 
orientation than the other.  This difference is subtle, however, as the two different 
heterotetramers have an overall r.m.s.d. of 1.2 Å between each other.  Individual 
subunits resemble one another closely through non-crystallographic symmetry 
relationships.  However, when overlaid, the differences between the two transporters 
are visible; one heterotetramer has the ATPase units pushed slightly together, with 
accompanying changes within the transmembrane domain (Figure 2.6).   The 
movement between these two states may be minor, but it extends across the whole 
transporter.  The cytoplasmic-facing portion of the transmembrane domains of the less 
inward-facing transporter is tilted closer to the translocation pathway.  The ATPase 
domains of the less inward-facing transporter are rotated slightly as well, and there is a  
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Figure 2.2. The E.coli methionine transporter MetN2I2 is a tetramer consisting of two copies of the 
transmembrane (MetI) permease protein (pink and green) in complex with two copies of an ATP 
binding cassette (MetN) protein (tan and purple).  The transmembrane protein consists of five 
transmembrane helices, with the N-terminus into the periplasm and C-terminus facing the cytoplasm.  
Each ATP binding cassette protein consists of a domain homologous with other ABC transporters and a 
C-terminal regulatory domain.  In this conformation, the two regulatory domains are in close contact, 
while the ATP binding cassette regions are held apart from one another.   
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Figure 2.3. A side view of the transporter clearly illustrates the asymmetry between the two chains of MetN.  
There is a two-fold axis of symmetry between each chain of MetI, but the relationship between the two copies of 
MetN is considerably more complicated.  The two copies of MetN are in different conformations, despite axes of 
symmetry between each domain when viewed separately. 
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Figure 2.4. The initial chain trace of the MetNI transporter (black) with the Xenon binding sites 
(red spheres) is shown above.  There were 17 total Xe atoms bound to the two transporters within 
the asymmetric unit. 
 
Figure 2.5. The asymmetric unit of the MetNI crystal form is shown below.  The two intact 
transporters are packed end to end.  There are other crystal contacts within the ATPase domain, but 
none within the transmembrane domain. 
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noticeable twist in the position of the ACT domain that makes up the C-terminal 
extension.  This movement may be indicative of the types of changes accompanying the 
large scale transition between the inward- and outward-facing conformations. 
Transmembrane Domain 
Each set of the membrane-spanning subunits of MetI are related by an 
approximate two-fold rotation axis (~180˚) and are otherwise essentially identical.  A 
subunit of the transmembrane domain MetI consists of 5 transmembrane helices 
organized similarly to the core of the membrane-spanning subunits of ModB, MalF, and 
MalG, as ModB, MalF, and MalG contain an N-terminal helix not seen in MetI (Figure 
2.7).  As a result, the N-terminus of MetI lies in the periplasm, while the C-terminus  
Figure 2.6. Above is an overlay of the two full transporters within the asymmetric unit.  While the 
transmembrane domains and homologous ATPase regions possess small differences, there is a much 
larger range in the position the C-terminal extension, shown with the brown, purple, green, and tan 
regions representing this extra ACT-like domain  
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protrudes into the cytoplasm, a difference from other observed structures that all 
possess an even number of transmembrane helices per monomer and consequently 
have both termini in the cytoplasm.  Helix TM 1 begins in the periplasm and forms a 
diagonal across the outside face of the other four helices, while TM 2 is a kinked helix 
that traverses from the cytoplasmic edge of the membrane back towards the periplasm.  
A loop helps to transition into TM 3, which leads to the short “coupling helix” that 
interfaces with the ATPase domain and, along with TM 4 makes up the central core of 
the translocation pathway.  The C-terminal TM 5 helix traverses the membrane once  
Figure 2.7. The five transmembrane helices that make up the core of the transmembrane domains of 
MetI (pink), ModB (green), MalF (blue) and MalG (purple) are closely related in structure.  Above is 
a picture of the core of these four transmembrane domains superimposed. 
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more, ending in the cytoplasm, on the opposite side from TM2, as these two helices 
form the outer core of the helices close their counterparts on the other monomer.   
Comparisons to other ABC transporters such as BtuCD and HI1470/1 are 
difficult, as the helical structure of these 10-helix domains differs significantly from the 
MetI structure, resulting in distinct organizations.  When comparing individual 
subunits, the root mean square deviation (r.m.s.d.) of structurally equivalent Cα atoms 
of ModB and MetI is ~3.4 Å, that of MalG and MetI is ~2.7 Å, and that of MalF and 
MetI is ~2.6 Å (Figure 2.7).  The relative positions of the two copies of MetI 
demonstrate a wider, more inward-facing conformation than either the ModB or the 
MalFG dimers.  Interestingly, the region of highest sequence similarity between these  
Figure 2.8. The diagram above illustrates the difference in translocation pathways (showing the 
coupling helix and the two helices on either side) between MetI (pink), ModB (green), and MalFG 
(blue).  The MetI model clearly shows a much larger pathway with the coupling helices tilted much 
further away from the translocation pathway than the ModB or MalFG transmembrane helices. 
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structures consists of the previously named “coupling helix” and the two 
transmembrane helices on either side, the region which forms the central core of the 
translocation pathway (Table A1.1).   
The coupling helix and the neighboring transmembrane helices display the most 
significant change between the nucleotide-free, inward-facing MetI conformation and 
the ATP-bound, substrate-occluded MalFG conformation.  For MetI, these elements 
correspond to TM3-coupling helix-TM4, while on MalF this region corresponds to 
TM6-coupling helix-TM7, and for MalG and ModB it is TM4-coupling helix-TM5, due 
Figure 2.9. The coupling helix and the segments of helices in close proximity to this helix display a 
large change between the nucleotide-free, inward-facing MetI conformation (pink) and the ATP-
bound, substrate-occluded MalFG conformation (purple), with the ModB conformation (green) 
appearing as an intermediate between the two.  Rotational motion towards the translocation pathway 
accounts for the major differences between the MetI and MalFG conformations; the opposing 
transmembrane domains were superimposed to highlight this movement. 
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to their N-terminal extensions beyond the 5-TM core shared by all four proteins.  As a 
whole, this region in MalFG exhibits the greatest shift toward the translocation 
pathway, as the two transmembrane helices are pushed closer to the central axis of the 
translocation pathway than those of MetI or ModB (Figure 2.8 and Figure 2.9).  This 
movement is presumably crucial to activating the permease pathway for transport; the 
communication between the ATPase domain and this transmembrane region is 
accomplished through a translation of the coupling helix toward the translocation 
pathway to allow for ATP hydrolysis and transport.  Superposition of this region of the 
MalFG dimer with the corresponding portion of the MetI dimer illustrates this tilt of the 
cytoplasmic-proximate region of the MalFG transmembrane domain towards the center 
of the translocation pathway as compared with MetI2, with ModB2 appearing as an 
intermediate between these two states.  The TM3 helix on MetI exhibits a rotation of 
approximately 22˚ away from the translocation pathway as compared with TM6 (TM 
6) of MalG (MalF), while the TM4 helix of MetI is similarly rotated approximately 24˚ 
away from MalFG, with the greatest distance on the cytoplasmic-facing region of these 
helices being roughly 10 Å.  The difference in positions of the coupling helices 
themselves appear based on a translational shift towards the translocation pathway 
rather than a tilting movement.  These short helices, part of the EAAXXXG motif 
previously described by Saurin et al. (1994), exhibit considerable sequence similarity, 
and each possess an important glutamate residue.  This residue, Glu121 in MetI, is 
thought to modulate the relationship between the TMD and NBD through a salt bridge 
with an arginine, present in MetN as Arg47.  The coupling helices in MetI appear to be 
shifted away from the translocation path by approximately 8 Å from the corresponding 
residues on MalFG, with a minimal change in the slope.  Conversely, the periplasmic-
adjacent regions of MetI2, MalFG, and ModB2 show considerable overlap, supporting 
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the hypothesis that movement of these transmembrane domains is tweezer-like 
depending on the state of nucleotide binding.  Additionally, the similarities extend to 
TM2 of MetI (and its equivalents in ModB, MalF, and MalG), particularly with respect 
to the shared helix length (a short 15 residues) and a kink in the helix caused by a 
proline residue (Pro67 in MetI). 
ATPase Domain 
The MetN ATP binding cassette protein consists of two domains, the 
approximately 225 amino-acid ATPase domain that is homologous with many other 
ABC transporters, and a C-terminal domain, comprised of the last 118 residues.  The  
 
 
 
 
 
Figure 2.10. A comparison of the structural motifs (labeled above) present in each of the previously 
studied ATP binding cassettes is shown here.  In each case, one ATPase subunit was superimposed 
with the MetN subunit shown in purple.  The right side of the diagram shows the placement of the 
maltose transporter (green), the molybdate transporter (gold), the metal-chelate transporter (red) 
and the vitamin B-12 transporter (blue).  The MetN subunits are clearly further apart than any 
others, and are separated by both a translation and rotation. 
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ATPase domain of the methionine transporter possesses the characteristic features 
shared by many ABC transporters that were first identified in the structure of HisP 
(Hung et al., 1998).  Similar to other characterized ATPase domains, the MetN 
monomer possesses a six-stranded β-sheet with strand order 2-3-4-1-5-6, with strand 
6 being antiparallel to the five other strands.  This domain possesses another β-sheet, 
comprised of four β-strands in an antiparallel structure with strand order 2-1-3-4.  
The two sheets surround one of the α-helices, and are bordered by another 8 helices 
that make 
up this domain.  The features found in this structure are similar to those described in 
the structure of HisP, which further divided the ATPase structure into two separate 
domains consisting of an α- plus β- type structure in one domain and a primarily 
helical second domain.  Interestingly, when this overall fold was first identified, it was  
 
 
Figure 2.11. A top-down view of the ATP-binding cassettes of MetN (purple) and MalK 
(green) reveals differences in the relative positions of conserved motifs in a simpler view.  
The Walker A, Walker B, and Signature motifs are highlighted (see Figure 2.10 for labels).  
In this cartoon, the alignment is based on both subunits in the dimer. 
 
- 41 - 
 
 
 
 
 
 
shared by no other structures within the PDB (Hung et al., 1998).  Since that time, 
however, it has been established as a common, homologous fold amongst the ABC 
transporter family, as both importers and exporters share these features.  The HisP and 
subsequent ABC transporter ATPase structures also elucidated certain motifs present 
within this family, which have been identified within the MetN structure.  The Walker 
A/B motif includes residues 38-45 and 161-165, while the signature sequence extends 
from 141-145 (Figure 2.10, Figure 2.11, and Figure 2.12). 
When comparing the homologous regions of various transporter structures to 
MetN, r.m.s.d. values of structurally equivalent Cα atoms for the individual subunits 
were 1.7 Å with HI1470, 1.8 Å with ModC, 2.3 Å with BtuC, and 2.6 Å with MalK.  
Interestingly, the monomer with the highest level of sequence homology to MetN is 
HisP, which has not been solved as a full transporter.  HisP and MetN have an r.m.s.d. 
Figure 2.12. Another top-down view of the ATP-binding cassettes of MetN and MalK displays the 
P loop and associated helix, the Walker A loop and associated helix, and the Q loop (Q).  This 
view more clearly depicts the rotation or swinging motion that must occur to move between these 
two conformations, as the helices especially are at different angles 
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of 1.8 Å.  While each of the 5 ATP binding cassettes from the structures of full 
transporters are relatively closely related in structure, the positions of the components 
within the respective dimers varies significantly depending on the overall transporter 
conformation.  The MetNI dimer reveals a more pronounced inward-facing 
transporter, with a much greater distance between the ATPase subunits than any other 
transporter structure solved at present.  While the recently published MalK structure 
depicts the conformation of the ATP-bound state (Oldham et al., 2007), the 
organization of MetN portrays an inward-facing conformation with widely separated 
NBDs.  The contrasting relationship between the MalK dimer and the MetN dimer 
suggests that a tweezer-like swinging motion brings the two subunits together (Figure 
2.12).   The rotational and translational shift between the MetN closed state and the 
substrate-bound conformation of MalK is more significant than the differences 
observed between other inward- and outward-facing conformations, such as the 
changes between the conformations of HI1470/1 and BtuCD.  The regions closest to 
the membrane appear to experience the most significant movement between the two 
states; this corresponds with the cytoplasmic-facing rearrangement between the 
transmembrane helices, suggesting that the central portion of the transporter 
undergoes the greatest shift through the transport process.  More simply, the ATP 
binding cassette dimer moves between open and closed states in a tweezer-like 
swinging motion that is similar to the motion of the transmembrane domain yet in the 
opposite direction.  The differences in distance between the motifs of the catalytic core 
on each subunit of the MetN dimer versus the MalK dimer are considerable, as the 
distances between corresponding residues on MalK are 10 Å closer together than those 
on MetN, on average.  Using residues of the P-loop and the signature motif, the 
intersubunit differences between opposing residues on the MetN dimer are 
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approximately 28 Å.  In contrast, these differences shrink to 11 Å and 16 Å for the 
maltose and molybdate structures and to 14 Å and 16 Å for BtuCD and HI1470/1 
(Pinkett et al., 2007).  The swinging motion is more apparent when residues on the 
periplasmic-proximate and the membrane-proximate regions of these two dimers are 
considered: distances between residues on the periplasmic face are considerably shorter 
than distances on the membrane facing region.  The MetN conformation is clearly only 
open to the cytoplasm, and this arrangement may be modulated by the C-terminal 
domain of the ATP binding cassette.  
Regulatory Domain 
The C-terminal domain of the MetN subunit consists of two elements: a 
regulatory domain, and a linker region connecting the regulatory and ATPase domains. 
Co-crystallization of MetNI with high concentrations (1mM) of L-selenomethionine 
revealed two clear selenomethionine binding sites in the C-terminal region of MetN.  
This domain, separated from the ATP binding cassette domain by a series of short 
helices and loops, exhibits a ferredoxin-like fold that consists of an α/β sandwich with 
an anti-parallel β-sheet.  The two copies of MetN interact in this region to form a 
dimer; each copy shares the βαββαβ topology and together an 8-stranded β-sheet is 
formed.  Previously named an ACT domain by Aravind and Koonin (1999), this dimer 
is a structurally conserved, regulatory ligand-binding domain thought to be fused onto 
a variety of proteins important in amino acid metabolism through the course of protein 
evolution (Chipman and Shaanan, 2001).   Structural studies of 3-phosphoglycerate 
dehydrogenase, a previously identified member of this family, revealed that the ACT 
domain binds serine as an allosteric regulator in the same position as that seen in MetN, 
supporting the hypothesis that the ACT domain shares a common ligand-binding mode, 
despite differing substrates (Schuller et al., 1995).  In addition, the regulatory and  
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catalytic domains of 3-phosphoglycerate dehydrogenase are separate, just as the ATP 
binding cassette and ACT domain of MetN are clearly divided by a linker region.   
In MetN, movement of these two domains relative to one another is 
accomplished through a hinge mechanism within the linker region.  The linker itself  
comprises the 40 residues in between the regulatory and ATPase domains, and 
possesses four short α-helices and five loop regions.  The transporter structure has 
revealed two different conformations of this linker region, resulting in an asymmetrical  
Figure 2.13.  A view of the two different conformations of the linker region is shown above.  The two 
chains of MetN (in purple and tan) align well over most of the structure, yet they diverge into two 
different conformations within this linker region (above, center).  
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relationship of the two MetN chains (Figure 2.13).  The ATP binding cassette region as 
well as the ferredoxin-like fold of the C-terminal extension exhibit approximate two- 
fold rotational symmetry between the two chains, but the rotation axes for the C-
terminal extension and the ATP binding cassette differ in orientation by approximately 
20˚.  These two orientations account for the asymmetry seen in the structure, and are 
the result of two different conformations of the linker region.  This hinge mechanism, 
observed in MetN through differing conformations of the linker region between the two 
domains, is most likely responsible for the movement between varying states of the ACT  
Figure 2.14. A close-up side view of the ACT domain shows an 8-stranded β-sheet formed by the 
interface of the two monomers.  The selenomethionine binding sites, depicted with blue density at a 
~6 σ contour level, are at the dimer interface, and are bordered by the four helices also part of this 
dimer. 
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domain.  The two ACT domains are in closer proximity to one another than the 
remainder of MetN, suggesting that this conformation is keeping the ATP binding 
cassettes from interacting, thereby blocking ATP binding and methionine transport 
(Figure 2.14, Figure 2.15, and Figure 2.16).  While the methionine binding site was not 
well characterized at this resolution, the binding sites are located in close proximity to 
Met301 and Met312.  This unusual feature could be an indication that there is 
competition between intercellular and intracellular methionine binding at this site.  
Biochemical studies corroborate that high methionine levels inhibit transport (Zhang, 
2003).  Interestingly, no selenomethionine was bound in any region of the  
Figure 2.15.  Another view of the ACT domain depicts the two methionines side-by-side within this 
dimer interface.  Allosteric ligand binding at this same location is found throughout other members of 
the ACT family.   
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transmembrane domain, suggesting that the ACT domain has a higher affinity for 
selenomethionine than the translocation pathway.  The presence of a regulatory domain 
may indicate that transport in these regulated ABC transporters is substrate need-
dependent, as MetNI is inactivated with high levels of intracellular methionine.  This 
regulatory activity adds a further dimension to the current models of ABC transporter 
mechanisms, suggesting that transport is primarily dependent upon the need for 
Figure 2.16. Above is a bottom-up view of the C-terminal ACT-like domain, showing the L-
selenomethionine binding sites at the interface of this dimer. 
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substrate rather than simply the presence of ATP and substrate delivered by a cognate 
binding protein. 
In conclusion, this structure has provided insights onto the structural 
organization of ABC importers.  First, this structure has identified the smallest 
transmembrane domain characterized thus far, suggesting that these 5 helices form a 
minimal core for an adequate translocation pathway.  Second, the ATPase domains are 
stabilized in a conformation with a much greater distance between the two subunits 
than seen before.  Third, the regulation of transport is modulated by a previously 
identified regulatory domain, and in cases of ligand binding in this area, the transporter 
is stabilized in an inward-facing conformation that precludes ATP binding.  This 
mechanism supports earlier findings by Kadner and allows for insight into the 
molecular mechanism of this regulatory mechanism, providing a better understanding 
of how transporters can be regulated at the level of protein function. 
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Appendix One. Methods and Data Relevant to Chapter Two. 
A1.1. Materials and Methods 
Cloning and Expression 
The E.coli methionine ABC transporter operon was identified from the NCBI 
website.   Following a similar strategy used in the BtuCD and HI1470/71 structure 
determinations (Locher et al. 2002, Pinkett et al. 2007), metN and MetI were cloned 
from E. coli K-12 genomic DNA (American Type Culture Collection) into a modified 
fusion pET21b(+)/pET19b vector that can co-express the metI and metN genes 
simultaneously using separate T7 promoters. The entire MetNIQ operon was isolated 
from the genomic DNA by PCR and inserted into a pCR-Blunt II-TOPO vector 
(Invitrogen).  The metN (ATPase subunit) gene was subsequently isolated by PCR using 
two oligonucleotides which inserted NdeI and XhoI sites. The PCR fragment was ligated 
into a pET19b vector (Novagen/EMD) using the NdeI and XhoI sites to introduce an N-
terminal 10xhistidine tag.  Similarly, the metI (transmembrane subunit) gene was 
isolated by PCR using two oligonucleotides which inserted NdeI and XhoI sites and 
removed the STOP codon from the end of the gene. The PCR fragment was ligated into a 
pET21b (+) vector (Novagen/EMD) using the NdeI and XhoI sites to introduce a C-
terminal 6xhistidine tag. 
The metI gene was isolated by PCR using the metI-pET21b (+) plasmid as the 
template with two oligonucleotides designed to anneal upstream and downstream of 
the entire promoter/expression region of the pET21b (+) plasmid, and introduce SphI 
and BglII sites at the ends of the PCR product.  This PCR fragment was digested with 
SphI and BglII and ligated into the metN-pET19b vector.  The SphI and BglII sites in the 
metN-pET19b vector are located in a non-coding region of the pET19b plasmid.  The 
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modified pET19b vector can express the metI and metN genes simultaneously using 
separate T7 promoters.  A mutagenesis reaction was then performed on the metNI-
pET19b plasmid to insert a STOP codon immediately after the metI gene so that the C-
terminal 6xhistidine tag will not be expressed. The reaction was performed using the 
Quickchange Mutagenesis Kit (Stratagene).  As a result, the final plasmid contains an 
ATPase subunit with an N-terminal MGHHHHHHHHHHSSGHIDDDDKH sequence, 
while the transmembrane subunit has no additional residues.  The cloning was 
performed by Allen Lee. 
The cloned plasmid was transformed into BL21 (gold) cells (Novagen) and 
protein expression was carried out at 37˚C in Terrific Broth with 0.2 mg/mL ampicillin 
and 1% glucose instead of glycerol in an 80 L New Brunswick fermentor containing 60 
liters of medium.  The cells were induced at OD 600=4.0 with 2 mM IPTG for 2 hours 
before harvesting and storing at -80˚C. 
Purification and Crystallization 
In the purification of MetNI, 10 g of cell paste is re-suspended in 50 mL of a 50 
mM Tris pH 7.5, 20 mM imidazole, and 1 M sodium chloride solution with 40 mL 
dH2O added.  The solution is clarified using a homogenizer, after which 10 mL of a 
10% n-dodecyl-β-D-maltopyranoside (Anatrace) solution and a protease inhibitor 
tablet (Roche) is added, bringing the final concentration to 1% n-dodecyl- β-D-
maltopyranoside.   
The 100 mL solution was split into two solutions of 50 mL each and placed on 
ice.  Each of these solutions was sonicated using a program that allowed for 0.5 seconds 
on, followed by 1.5 seconds off, in one-minute increments.  The two solutions were 
alternatively sonicated for one minute each, until each solution was sonicated for a total 
of 4 minutes.  After sonication, the solutions were re-combined and stirred for 1 hour 
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at 4˚C before centrifugation at 39,700 x g for 30 minutes.  The supernatant was loaded 
and equilibrated onto a 5 g Ni-sepharose affinity chromatography column 
(Amersham), washed with 92 mM imidazole, and eluted with 250 mM imidazole, 25 
mM Tris pH 7.5, 500 mM NaCl, and 0.1% DDM.  The eluate was dialyzed overnight 
into a solution containing 0.1% DDM, 25 mM Tris pH 7.5, 500 mM NaCl, 5 mM 
dithiothreitol, 2.5 mM MgCl2, and 2.5 mM ATP before it was concentrated to 20 
mg/ml using an Amicon Ultra MWCO100 concentrator (Millipore).  Protein purity 
was estimated to be greater than 90% using SDS gel electrophoresis. 
Selenomethionine substituted protein was made using E. coli B834 (DE3) cells 
(EMD Biosciences).   Cells were grown in M9 medium supplemented with seleno-D,L-
methionine.  Procedures for purification and crystallization of the selenomethionine-
substituted protein were identical to that of the native protein. 
Crystallization experiments were carried out with the hanging drop method at 
20˚C, using 2 μL protein plus 2 μL precipitant solution.  Chunky, diamond-shaped 
crystals were obtained using solutions in the range of 28-32% PEG 400, 0.05 M Li2SO4, 
0.2 M (NH4)2HPO4, 0.05-0.15 M (NH2)2SO4, and 0.1 M Sodium Citrate pH 4.2-4.5.  
Crystals grew to 0.3 x 0.3 x 0.4 mm3 in two to three weeks, and were frozen in liquid 
nitrogen prior to data collection. 
Xenon-derivatized crystals were formed by exposing the native crystal to 100psi 
Xe gas for 10 minutes in a pressure chamber.  Selenomethionine-soaked crystals were 
obtained by soaking native crystals in 1-20 mM L-selenomethionine for 30 minutes to 
3 hours. 
Data Collection and Structure Determination. 
A 3.7 Å resolution native dataset was collected at the Stanford Synchrotron 
Radiation Laboratory beam line 11-1 and processed using MOSFLM and SCALA (Leslie, 
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1992).  A 3.8 Å resolution Xenon-derivatized dataset (1.5 Å wavelength) was collected 
at the Stanford Synchrotron Radiation Laboratory beam line 9-2 and processed using 
MOSFLM and SCALA.  A 3-wavelength 5.5 Å resolution dataset using 
selenomethionine-substituted crystals was collected at the Advanced Light Source beam 
line 8.2.1 and processed using MOSFLM and SCALA (Leslie, 1992).  A peak wavelength 
4.5 Å resolution dataset of an L-selenomethionine-soaked crystal was collected at 
Stanford Synchrotron Radiation Laboratory beam line 9-2 and processed using 
MOSFLM and SCALA.   
Initial protein phases and heavy atom binding sites were found from the Xe-
derivatized data using single isomorphous replacement in the program SHELX 
(Schneider and Sheldrick, 2002), and were further refined through solvent flattening 
and histogram matching using SHARP (Bricogne et al., 2003).  SIRAS was carried out in 
SHARP using the Xe-derivatized data with the native data and solvent flattening and 
averaging were performed using the programs MAIN and DM (Cowtan, 1994).  Jens 
Kaiser obtained the initial protein phases and heavy atom binding sites and established 
non-crystallographic symmetry.  Manual building was done in COOT (Emsley and 
Cowtan, 2004), and refinement was carried out using REFMAC and CNS (v 1.2) 
(Brunger, 2007).  The sequence register of the C-terminal extension of MetN was 
confirmed using a structure of this short, soluble domain solved by Eric Johnson. The 
sequence register of MetI was additionally confirmed using the structures of the 
molybdate and maltose transporters (Hollenstein et al., 2007; Oldham et al., 2007).  
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Figure A1.1. The sequence alignment of MetI, the transmembrane domain, with the transmembrane 
domains of MalF, MalG, and ModB, is shown above.  The highest level of sequence similarity is within 
the segment containing the coupling helix and extending to the helices on either side of this 
important helix.  This alignment was performed using MUSTANG (Konagurthu et al, 2006). 
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Figure A1.2. The sequence alignment of the ATP-binding cassette subunits is shown above.  Included are the 
maltose transporter and the molybdate transporter. This alignment was performed using MUSTANG 
(Konagurthu et al, 2006). 
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Figure A1.3.  Above are the experimental data regarding the purification of MetNI.  The top figure 
represents the chromatograph recorded during a typical purification.  The loading of the sample 
(onto a Ni-sepharose column)is followed by a washing step (2nd peak), followed by the elution of the 
purified protein with a solution containing 250 mM imidazole.  Below is a typical gel obtained in 
purification.  The first lane is a molecular marker.  The second, third, fourth and fifth lanes are the 
loaded sample, the resuspended pellet after centrifugation, a sample from the flow through and a 
sample from the wash step, respectively.  The remaining lanes represent the purified sample; at 23kD 
the lower band represents the transmembrane domain, while at 47kD the upper band represents the 
ATPase domain. 
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Figure A1.4. Above are pictures of crystals of the transporter.  These 
orthorhombic crystals formed in beautiful, large shapes.  The total crystal 
size was approximately 0.3 x 0.3 x 0.4 mm3.   
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Figure A1.5. Above is the initial density seen for the transporter, after phasing using Xenon 
and the initial solvent flattening using DM. 
- 58 - 
 
 
Table A1.1: Summary of Secondary Structure for MetN 
 
Secondary Structure Residue Range 
β1 1-11 
β2 17-28 
β3 32-39 
β4 59-65 
β5 67-70 
β6 84-89 
β7 160-170 
β8 193-199 
β9 209-215 
β10 218-223 
β11 266-273 
β12 295-303 
β13 309-318 
β14 334-343 
  
α1 42-62 
α2 75-82 
α3 99-108 
α4 114-127 
α5 130-135 
α6 144-156 
α7 174-190 
α8 201-206 
α9 234-239 
α10 242-249 
α11 252-258 
α12 281-290 
α13 322-331 
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Table A1.2: Summary of Secondary Structure for MetI 
Secondary Structure Residue Range 
  
α1 (TM 1) 8-41 
α2 (TM 2) 52-65 
α3 (TM 2) 68-82 
α4 (TM 3) 89-114 
α5 (coupling helix) 118-126 
α4 (TM 4) 131-166 
α5 (loop) 172-183 
α6 (TM 5) 186-207 
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Table A1.3: Processing, Phasing, and Refinement Statistics for Xe, Native and Se soak 
 
Data processing  
Dataset Xenon Native SeMet soak 
Spacegroup P 21 21 21 P 21 21 21 P 21 21 21 
Unit Cell dimensions (Å) a= 97.74 
b= 169.20 
c= 290.60 
a= 97.77 
b= 165.81 
c= 288.92 
a= 97.74 
b= 169.20 
c= 290.60 
Wavelength (Å) 1.5 1 .979 
Resolution (Å) 40-3.8  40-3.7  40-4.7  
Unique reflections 61583 68389 28494 
redundancy 8.0 (7.8) 11.3 (12.2) 7.4 (6.8) 
aCompleteness 99.9 (99.9) 94.3 (100.0) 97.5 (95.8) 
bRmerge .11 (.81) .11 (.92) .07 (.59) 
    
Phasing power from Xe dataset    
Isomorphous phasing power 
from (centric/acentric) 
.674/.771   
Anomalous phasing power  .744   
Figure of Merit 
(centric/acentric) 
.186/.257   
Figure of Merit after DM .74   
    
Refinementc    
Resolution (Å) 40-3.7    
Reflections used 49914   
Test reflections 5048   
dRWork (%) 31.0   
dRfree (%) 35.4   
Average B factor (Å2) 169.67   
Rmsd bond length (Å) 0.02   
Rmsd bond angle (°) 2.78   
    
Ramachandran (%)    
Most favored 91.0   
Allowed 4.2   
Disallowed 4.8   
aNumbers in parentheses refer to the highest resolution shell only. 
bRmerge=Σ|Ih-<I>h|/ΣIh, where <I>h is average intensity over symmetry equivalents. 
cThe data processing statistics describe the data sets used for the initial structure determination. 
The datasets were re-processed by Jens Kaiser for the final refinement and data deposition. 
dR-factor=Σ|Fobs-Fcalc|/ΣFobs. 
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Table A1.4: Processing, Phasing, and Refinement Statistics from Semet protein 
 
Data processing  
Dataset Peak Inflection Remote 
Spacegroup P 21 21 21 P 21 21 21 P 21 21 21 
Unit Cell dimensions (Å) a= 93.79           b= 159.59        c= 294.33 
Wavelength (Å) .9796 .9795 .972 
Resolution (Å) 30-6.0  30-6.0  30-6.0  
Unique reflections 22391 22386 22387 
redundancy 12.1 (12.6)  12.1 (12.6) 11.9 (12.2) 
aCompleteness 99.9 (100.0) 99.9 (100.0)  99.9 (100.0) 
bRmerge .153 (.47) .148 (.51) .149 (.50) 
 
aNumbers in parentheses refer to the highest resolution shell only. 
bRmerge=Σ|Ih-<I>h|/ΣIh, where <I>h is average intensity over symmetry equivalents. 
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Chapter Three.  MetQ. 
3.1 Introduction  
An integral component of the complete ABC importer system is the substrate 
binding protein; the substrate binding protein is responsible for the delivery of the 
substrate to the ABC importer.  In Gram-negative bacteria, this substrate binding 
protein is secreted and contained within the periplasm by the outer membrane.  In 
Gram-positive organisms, the substrate binding proteins are typically tethered to the 
plasma membrane in some manner, through a lipid anchor or through fusion to the 
membrane-spanning region of the transporter (Williams et al., 2004).  These substrate 
binding proteins (whether soluble proteins or lipoproteins) are responsible for binding 
a specific ligand and associating with the transmembrane domain of the ABC 
transporter to facilitate the transport of the substrate across the periplasm.  This 
mechanism of delivery helps to confer substrate specificity and affinity upon the ABC 
transporter (Tam and Saier, 1993).  Without its substrate binding protein, an ABC 
transporter is typically unable to retain its full activity and becomes a low-efficiency 
transporter.  Further supporting this idea is the evidence that Kd values for most 
substrate binding proteins are within an order of magnitude of the Km of the 
corresponding ABC transporter, suggesting that the binding protein delivery system is 
responsible for much of the transporter’s substrate affinity (Tam and Saier, 1993).   
The identification of these binding proteins and their relationship to transport 
was not fully elucidated until the early 1970s.  The first evidence that these proteins 
were located within the periplasm came from experiments that demonstrated their 
sensitivity to osmotic shock, leading to the ability to isolate these periplasmic proteins 
(Neu and Heppel, 1965).  This description of osmotic shock set off a plethora of further 
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studies concerning these unidentified proteins, leading to a hypothesis that they were 
important for bacterial transport (Barash and Halpern, 1971).  However, more definite 
genetic and biochemical proof of a link between these binding proteins and their 
involvement in transport was provided via a study of the galactose transport system.  
This study established that the galactose binding protein was a vital part of the 
galactose transport system by identifying a mutation that selectively disabled the 
galactose binding protein but did not affect the entire gene locus (Boos, 1972).  In the 
following years, X-ray structures of various periplasmic binding proteins were solved, 
although a further biochemical understanding of these systems was not yet achieved.  A 
study comparing the biochemical activities of a variety of periplasmic carbohydrate 
binding proteins suggested that the high affinity these proteins have for their respective 
substrates is responsible for a rapid response in binding.  Furthermore, it was proposed 
that these binding proteins confer the high specificity and sensitivity to their 
corresponding transport systems (Miller et al., 1983).  This concept, combined with the 
hypothesis that these proteins interact with their membrane-bound counterparts 
(Higgins, 1992), suggested a system that had multiple components working together to 
bind a substrate with high specificity and transport it across the membrane.  
Interestingly, many of these substrate binding proteins share structural 
similarity, as the structures have been revealed to be bi-lobed structures with two 
nonequivalent domains surrounding the ligand.  This is thought to be tied to 
evolutionary relationships between many of these substrate binding proteins, despite 
low sequence similarity between these proteins.  Numerous ABC importer substrate 
binding protein structures have been published over the past 30 years (Quicho et al., 
1996).  Among the published structures are those with ligands that are carbohydrates 
like the maltose or glucose/galactose binding proteins, amino acids like the 
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leucine/isoleucine/valine, histidine, or lysine/ornithine/arginine binding proteins, and 
other ligands such as the phosphate, vitamin B12, or sulfate binding proteins (Quiocho 
and Ledvina, 1996).  These structures demonstrate low sequence similarity, a lack of 
conserved sequences, and size deviations from one another, as the size of these proteins 
can vary from 23 kD to 60 kD.  However, the common feature shared among these 
structures is the presence of two distinct domains bisected by a hinged crevice that 
forms the ligand binding pocket and allows for movement between the ligand-bound 
and ligand-unbound states.  The two domains of the substrate binding protein are 
typically comprised of a β-sheet surrounded by α-helices.  Certain substrate binding 
proteins enclose the ligand completely, while in other cases, the ligand is in a somewhat 
solvent-accessible region (Quiocho and Ledvina, 1996).  Three groups of substrate 
binding proteins have been described based upon the connectivity between the two 
domains.  Group I binding proteins possess three short connecting segments between 
the two domains, resulting in the domains being comprised of separate segments from 
the first and second half of the entire polypeptide chain.  Group II binding proteins 
possess two crossovers between the domains, to form one domain from the N- and C- 
terminal ends of the polypeptide chain, and the second domain from the middle 
segment (Quiocho and Ledvina, 1996).  Group III binding proteins possess a single α-
helical connection between the two domains (Karpowich et al., 2003).  Examples of 
group I binding proteins include the maltose binding protein, the L-arabinose binding 
protein, and the leucine/isoleucine/valine binding protein.  The oligopeptide binding 
protein, the lysine/arginine/ornithine binding protein and the histidine binding 
protein are part of Group II of these binding proteins, while the vitamin B12 binding 
protein and a periplasmic metal binding protein are members of Group III (Lee et al., 
2002). 
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Mechanistically, these proteins are thought to be similar as well, utilizing a 
conserved mechanism named the “Venus flytrap mechanism,” according to Mao et al. 
(1982).  In this mechanism, the ligand-free protein adopts an open conformation, with 
the substrate binding pocket exposed to the solvent.  Substrate can subsequently bind, 
allowing for the substrate binding protein to move to a closed conformation with a 
tightly bound ligand that is shielded from solvent.  As the substrate binding protein 
docks onto the transmembrane permease protein, conformational changes resulting 
from the ATPase activity of the ABC transporter are thought to lead to movement of the 
transmembrane region, which is thought to pull apart the substrate binding domain, 
releasing the substrate into the translocation pathway of the permease (Williams et al., 
2004).  Originally, this hypothesis proposed that the “open” or non-ligand-bound state 
of the binding protein adopted a conformation in which the two lobes of the binding 
protein were 20˚ further apart than in the bound state (Mao et al., 1982).  
Interestingly, there are few binding protein structures that have been solved in both the 
ligand-unbound and ligand-bound conformations.  The first example was the maltose 
binding protein, which revealed a 35˚ rotation about the hinge upon ligand binding 
(Sharff et al., 1992).  Another comparison has been made for the vitamin B12 binding 
protein BtuF; in this case, there is relatively little structural change upon ligand 
binding, although substrate binding was shown to cause a decrease in mobility within 
the protein (Karpowich et al., 2003).  
More recently however, there have been a number of structures presented that 
illustrated the binding protein interactions with the transporter; these studies have 
helped to understand the mechanics involved in the binding protein-transporter 
interaction.  The structure of BtuF in complex with BtuCD, the only binding protein-
ABC transport complex without a ligand present, corroborates with the Venus flytrap 
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hypothesis.  The binding protein in this structure is seen in an open conformation, with 
the two lobes spread apart.  At the interface, loops from the BtuC permease insert into 
the B12 binding site, resulting in the open conformation for BtuF (Hvorup et al., 2007).  
This notion is further supported by the structure of the maltose binding protein in 
complex with the maltose transporter.  In this structure, the substrate maltose is 
present, but within the permease translocation pathway, not the binding protein.  
Interestingly, the maltose binding protein is an open state as well, and a loop from the 
MalG permease inserts into the binding site.  It has been hypothesized that this loop acts 
as a scoop, as it is responsible for dislodging the sugar and forcing it to transfer into the 
translocation pathway (Oldham et al., 2007).  The third structure of an intact 
transporter-binding protein complex, ModABC, possesses a ligand within the binding 
protein, suggesting that this conformation is pre-transport.  This interaction however, 
supports the notion that docking is mediated by attractions between oppositely charged 
amino acid side chains on both the permease and binding protein (Hollenstein et al., 
2007). 
Amino acid binding proteins exhibit a preference for ligands with similar 
structures and properties; certain proteins in this family can bind a group of similar 
amino acids, such as the leucine/isoleucine/valine binding protein.  The selectivity for 
these amino acids is determined by the binding pocket.  Hydrophobic residues line the 
active site for the leucine/isoleucine/valine binding protein, while the histidine binding 
protein presents polar hydrogen bonding sites as well as a π-stacking interaction via an 
active site tyrosine.  Similarly, the lysine/arginine/ornithine binding protein has a 
binding site lined with acidic amino acids to form salt bridges with the substrate.  Di- 
and tri-peptide binding proteins are also within the category of amino acid binding 
proteins, and exhibit similar properties.  The amino acid binding proteins share certain 
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structural features as well: both domains participate in the ligand binding, water 
molecules are frequently present in the ligand binding site, and a hinge-bending 
motion is thought to be responsible for the difference between the open (apo) and 
closed (ligand-bound) states of these binding proteins (Quicho et al., 1996).   
3.2 Methionine Binding Proteins 
The structure of a methionine binding protein from the MUT family from 
Treponema pallidum, the organism responsible for the disease syphilis, has been solved 
previously to 1.85 Å resolution (Deka et al., 2004). The structure of this protein (PDB 
ID: 1XS5), called tp32, resembles other periplasmic ligand-binding proteins and is 
thought to be a lipoprotein in physiologic conditions (Figure 3.1).  As is common for 
these binding proteins, tp32 possesses two α/β domains that are linked by two 
crossovers.  The binding pocket is located between these two domains, and an L-
methionine residue was present in the electron density map.  Each domain consists of a 
central core, comprised of a five stranded β-sheet with α-helices on either side.  In each 
β-sheet, there is one anti-parallel strand.  While one of the regions connecting the two 
domains possesses no secondary structure, the other features a short 310 helix that is 
proximal to the methionine binding site.  The binding pocket was identified to contain a 
non-covalently bound molecule of L-methionine, identified by shape and through an 
anomalous difference Fourier analysis of protein from a selenomethionine-containing 
sample.  The binding of the L-methionine was unexpected, as no exogenous methionine 
was added to the medium, or to any of the purification steps; the methionine must be 
bound tightly enough to survive through multiple purification steps after the initial 
growth, and the protein must be selective enough to avoid binding any of the other 
small molecules (amino acids and numerous other small metabolites) in the growth 
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medium.  The binding pocket has polar and charged residues around the amino and 
carboxyl groups of methionine, which are expected to be charged at physiological pH.  
These charges are neutralized by Glu87 and Arg119.  To stabilize the hydrophobic side 
chain of the methionine residues, Phe61 and Tyr44 participate in van der Waals 
contacts with the S-methyl group.  Other hydrophobic residues stabilize the side chain, 
while a polar residue (Asn116) hydrogen bonds to the sulfur atom of the methionine 
residue.  Deka et al. (2004) describe the active site as being particularly well suited to 
binding methionine, between the van der Waals contacts, the stabilization of the main 
chain atoms and their charges, and the hydrogen bonding of the sulfur atom.  
Interestingly, they found it difficult to remove methionine from the binding site and 
efforts to crystallize an apo form proved impossible.  Approximately 20% of the protein 
denatured with guanidine hydrochloride and later renatured was found to have L-
methionine still bound.   
In addition to the structure described above, the structure of a glycylmethionine 
Figure 3.1. Above is the structure of the methionine binding protein tp32 from Treponema pallidum.  
The bound ligand, methionine, is shown in black. 
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dipeptide binding protein from the MUT family of Staphylococcus aureus has been 
solved to 1.7 Å resolution in complex with its substrate (Williams et al., 2004).  The 
structure of this protein, pg110 (PDB ID: 1P99), is quite similar to that of tp32, and 
demonstrated to be a lipoprotein by Williams et al. (2004).  The structure of pg110 is 
made up of two domains in a similar fashion to tp32 (Figure 3.2).  The ligand bound in 
this structure clearly showed a glycine-methionine dipeptide, suggesting a high 
specificity for this ligand, as other dipeptide binding proteins frequently are crystallized 
with a heterogeneous mix of peptides present in the binding site.  To stabilize the 
methionine side chain, a hydrophobic pocket is formed by Phe82, His79, Phe77, and 
Tyr60.  Asn192, Asn223, and Arg136 form hydrogen bonds with the carboxylate 
group from the methionine, while Arg144 appears to form a salt bridge to neutralize 
the carboxylate charge.  Ser32 forms a hydrogen bond with the N-terminus of the 
peptide, which also forms a water-mediated hydrogen bond to Asp34 and Glu261.  The 
glycyl-carbonyl group is stabilized with hydrogen bonding from Gly194 and Tyr60.  
Analysis by Williams et al. (2004) suggests that glycine is the only other residue besides 
Figure 3.2. Above is a cartoon of the glyclmethionine dipeptide binding protein from S. aureus.  This 
structure was solved with the glycylmethionine dipeptide bound, shown in black. 
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methionine that can be accommodated by this active site, suggesting a high specificity 
for the Gly-Met dipeptide.  Overall, the peptide is completely inaccessible to solvent, 
and fourteen different residues help to stabilize ligand binding.   
3.3 Structural Analysis of MetQ 
The structure of the cognate binding protein to the MetNI system, MetQ, was 
solved to 1.8 Å resolution using molecular replacement with a modified version of the 
protein pg110 (PDB ID: 1P99) (Figure 3.3).  An L-methionine was discovered in the 
ligand binding pocket, presumably carried over from the expression process, a 
phenomenon seen with other binding proteins due to the high binding affinity.  The 
ability of this protein to bind D-methionine was not elucidated in these studies, 
although this methionine transporter will import D-methionine (Kadner, 1974).   
The structure itself displays a similar organization to other periplasmic ligand 
binding proteins, and shows the ligand binding domain to be at the interface of the two 
domains characteristic of this family of proteins.  Similar to other methionine or 
glycine-methionine dipeptide binding proteins, the two domains of MetQ are connected 
by a linker region that plays a significant role in methionine binding.  Unlike tp32, 
however, both linker regions are loops, as MetQ does not possess the 310 helix thought 
to play a role in methionine binding in tp32.  The topology of MetQ is similar to both 
the methionine-binding tp32 and the glycylmethionine-binding pg110, as expected 
from the sequence identity of 39% and 35% to pg110 and Tp32, respectively, and as 
reflected in the overall r.m.s.d.s between these proteins of 1.3 to 1.5 Å (Figure 3.4).   
Domain I of the protein is slightly smaller and consists of a 5-stranded β-sheet with 
strand order 9-5-8-6-7, with strand 5 anti-parallel to the others, surrounded by 2 α- 
helices and 3 310 helices.  Domain II, however, is larger and consists of a longer 5- 
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Figure 3.3.  An overall view of the structure of the MetQ methionine binding protein (blue) 
illustrates the two lobes present in this structure, on either side of the bound methionine (gold).   
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stranded β-sheet with strand order 2-1-3-10-4, with strand 10 anti-parallel to the 
others, surrounded by 4 α-helices on one side and 2 α-helices on the other.  The first 
domain possesses all of the 310 helices, and interestingly has many more loops than the 
second domain, which has larger helices and a considerably longer β-sheet.   
The binding pocket appears to be well suited for L-methionine binding, and 
possesses active site features found in pg10 and tp32 (Figure 3.5).  The C-terminal 
negative charges of the L-methionine ligand hydrogen bond with Asn229 and a water 
molecule on the first oxygen, while Arg144, Asn202, and another water molecule form 
salt bridges and hydrogen bonds with the second oxygen.  The N-terminal positive 
charge is balanced by a salt bridge with Glu42, and hydrogen bonding to Thr204, 
Asn229, and another water molecule.  The most hydrophobic portion of the side chain, 
the β and γ carbons, are in van der Waals contacts with Tyr69 and His88.  The 
Figure 3.4. Above is an overlay of the three methionine binding proteins: MetQ (blue), tp32 
(brown), and pg110 (green).  The ligands (in the respective colors) for each are shown in the 
ligand binding site.  Overall, there is high similarity in the folds of these proteins, as well as a 
high degree of similarity within the active site. 
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hydrophobic methyl group of the ligand is proximate to Tyr69, Tyr91, and Phe86, and 
the methionine Sδ forms a hydrogen bond with Gln87 and possibly Asn141, resulting 
in a tight fit for the ligand.   
Many of the residues within the ligand binding site of MetQ have equivalent 
counterparts in tp32 and pg110 (Figure 3.5).  Residues Arg144, Asn202, and Asn229, 
important in the negative charge neutralization for MetQ, have equivalents in tp32 as  
Figure 3.5. A close-up view of the ligand binding site presents the residues important for ligand 
binding as well as numerous binding site waters (gold) that are important for stabilizing the ligand.  
Residues and waters participating in hydrogen bonding are marked with dashed black lines. 
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Arg119, Asn175, and Asn202; and Arg151, Asn207, and Asn238 in pg110.  Similarly, 
the van der Waals contacts of Tyr69 in MetQ are played by Tyr44 in tp32 and Tyr75 in 
pg110.  Another important residue, Phe86, has counterparts in Phe61 and Phe92 of 
tp32 and pg110, respectively.  Also stabilizing the Sδ in all three proteins is a histidine 
residue: His88 in MetQ, His63 in tp32, and His94 in pg110.  The residues stabilizing 
the positively charged N-terminus also vary slightly.  There is a counterpart for Asn229 
in tp32 and pg110 (Asn202 and Asn238, respectively), but the similarities end there.  
The protein pg110 only has one residue to stabilize this nitrogen, as instead of a free 
amino group, the nitrogen participates in a peptide linkage with glycine.  MetQ and 
Figure 3.6.  An overlay of the lysine/arginine/ornithine binding protein (brown) and MetQ is 
shown above.  The LAOBP possesses two protrusions on one end of the structure, while the 
MetQ protein has a protuberance on the opposite face.  The residues important for docking of 
the binding protein onto the transporter remain unclear. 
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tp32 both possess a water molecule and a glutamate (Glu42 in MetQ and Glu87 in 
tp32) to further accommodate the positive charge of the amino group.  Perhaps the 
biggest difference between these three ligand binding sites, besides the slight difference 
in ligand (L-methionine versus the glycine-methionine dipeptide), is in the residue that 
participates in stabilizing the S-methyl group of the methionine side chain.  In MetQ, 
this function is carried out by Tyr91, but in tp32 this is fulfilled by His66, and in pg110 
by Phe97.  While these residues do share hydrophobic properties, it is interesting to see 
a range of residues in this location.  As previously mentioned, the greatest difference 
between pg110 and the other L-methionine binding proteins is that pg110 binds a 
glycyl-methionine ligand, and its active site is therefore somewhat more spacious.     
The overall fold of these methionine binding proteins is similar to the histidine 
Figure 3.7. The surface electrostatics of the MetQ binding protein is shown above.  A cartoon is 
shown beneath the surface in yellow.  Gray spots indicate neutral charge, while red spots indicate 
negatively charged residues and blue spots indicate positively charged residues.   
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binding protein (PDB ID: 1hpb), the lysine/arginine/ornithine binding protein (PDB 
ID: 1lst), and the glutamine binding protein (PDB ID: 1wdn).  Superimposition of the 
analogous Cα atoms of MetQ results in r.m.s. deviations of about 3.2 Å with the 
histidine binding protein HisJ, 3.4 Å with the lysine/arginine/ornithine binding protein 
LAOBP, and 3.1 Å with the glutamine binding protein QBP.  An overlay of MetQ with 
the LAOBP is shown in Figure 3.6.  Outside of the central domain, there are some 
differences between these structures.  Two protrusions identified in the glutamine 
binding protein are not present in MetQ; these protrusions are hypothesized to form an 
interaction with the transmembrane domain of the ABC transporter.  However, the 
Figure 3.8. A comparison of the connector helices in the three methionine binding proteins is above.  
The connector helices are near the center of this cartoon in green (pg110) and brown (tp32), yet the 
blue cartoon (MetQ) has no helix in this region. 
- 77 - 
 
 
methionine binding proteins have a slightly different protuberance that is different than 
those in the histidine binding protein, and it was hypothesized by Deka et al. (2004) 
that this protuberance plays a role in docking on to the transmembrane domain of an 
ABC transporter.  In MetQ, the protuberance is proximal to a slightly negatively 
charged patch of the protein, further encouraging the notion that this region plays a 
role in forming a salt bridge with the ABC transporter during the docking process 
(Figure 3.7).  The precise interaction of MetQ with MetNI is currently unknown, 
although purified MetQ forms a complex with MetNI in dodecyl maltoside and co-elute 
on a size exclusion column.  There have been hypotheses posed regarding the nature of 
this interaction, but further studies are necessary before this can be fully understood.   
Another significant difference between the published methionine binding 
proteins and these other amino acid binding proteins is present in the secondary 
structure of the connector regions between the two domains.  In other group II binding 
proteins, such as the histidine binding protein, the lysine/arginine/ornithine binding 
protein and the glutamine binding protein, the connector regions have no secondary 
structure.  In the LAOBP, this region corresponds to residues 190-195.  The two 
published methionine binding proteins however, contain a 310-helix in the connector 
region, which has thus far only been found in methionine binding proteins (Figure 
3.8).  It has been hypothesized that this small helix may act as a restraint in movement 
between the apo and ligand-bound forms of the protein, thus moving less than the 
other, less constrained amino acid binding proteins.  MetQ is more similar to the other 
amino acid binding proteins, as it differs from the other methionine binding proteins 
and does not possess this short helix in the ligand binding domain.  The ligand binding 
domain also differs between these two groups of structures.  Interestingly, the 
orientation of the methionine in the methionine binding protein is rotated ~90˚ relative 
- 78 - 
 
 
to the amino acids bound in the other amino acid binding proteins (Deka et al., 2004).  
In conclusion, the MetQ structure shares certain features with other methionine 
binding proteins, but possesses key differences relative to ligand specificity from other 
amino acid binding proteins within the periplasmic binding protein-like superfamily. 
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Appendix Two. Methods and Data Relevant to Chapter Three.  
A2.1. Materials and Methods 
Cloning and Expression 
The E. coli methionine ABC transporter operon was identified from the NCBI 
website and purified genomic DNA was obtained for E.coli K-12 strain from ATCC 
(American Type Culture Collection).  The E. coli metQ (periplasmic binding protein) 
gene was isolated by PCR using two oligonucleotides which inserted NdeI and XhoI sites 
while removing the STOP codon. The PCR fragment was ligated into a pET21b(+) 
vector (Novagen/EMD) using the NdeI and XhoI sites to introduce a C-terminal 
6xhistidine tag. The cloned plasmid was transformed into BL21-gold (λDE3) cells 
(Novagen/EMD).  The cloning was performed by Allen Lee. 
Protein expression was carried out at 37˚C in Terrific Broth with 0.2 mg/mL 
ampicillin and 1% glucose instead of glycerol in an 80 L New Brunswick fermentor 
containing 60 liters of medium.  The cells were induced at OD 600=4.0 with 2 mM 
IPTG for 2 hours before harvesting and storing at -80˚C. 
Purification and Crystallization 
In the purification of MetQ, the resulting cell paste was subjected to osmotic 
shock to obtain the periplasmic extract.  Approximately 20 g of cells were re-suspended 
into 20 mL of an osmotic shock solution containing 40% sucrose, 1 mM EDTA, and 10 
mM Tris pH 7.5 for 1 hour.  The osmotic shock solution was then transferred into 1 
liter of dH2O and stirred for 10 minutes before buffer components were added for the 
final solution to contain 250 mM NaCl, 25 mM Tris 7.5, and 17 mM Imidazole.  The 
resulting periplasmic extract was centrifuged at 37500 x g for 30 minutes, loaded on to 
a 10g Ni-Sepharose column (Amersham), equilibrated with a buffer of 250 mM NaCl, 
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25 mM Tris pH 7.5, and 17 mM Imidazole, and finally eluted with a150 mM imidazole 
buffer.  The resulting protein solution was dialyzed into 250 mM NaCl and 25 mM Tris 
7.5 overnight before it was concentrated to approximately 25 mg/mL using an Amicon 
10 kD MWCO concentrator (Millipore).  Protein purity was estimated to be greater 
than 90% using SDS gel electrophoresis. 
Crystallization experiments were carried out with the hanging drop method at 
20˚C, using 2 μL protein plus 2 μL precipitant solution.  Thin needle-plate crystals were 
obtained in 30% PEG 4000, 0.1 M sodium citrate pH 5.6, 0.2 M ammonium acetate.  
These crystals were used to micro-seed a 28% PEG 4000, 0.1 M sodium citrate pH 5.86, 
0.2 M ammonium acetate, and 4% PEG 400 solution using 2 mg/mL protein, in order 
to obtain larger, single crystals.  Crystals grew to 0.6 x 0.2 x 0.1 mm3 in less than a 
week, and were frozen in liquid nitrogen prior to data collection. 
Data Collection and Structure Determination. 
A 1.8 Å resolution native dataset was collected at the Stanford Synchrotron Radiation 
Laboratory (SSRL) beam line 9-2, and processed using MOSFLM and SCALA (Leslie, 
1992).  Protein phases were determined using molecular replacement (MOLREP) 
(Vagin and Teplyakov, 1997) using pg110 (PDB ID: 1P99), a Gly-Met binding protein 
with 39% sequence identity.  For molecular replacement, loops were deleted and non-
identical residues were mutated to serines.  The structure was primarily built using 
Arp/wArp (Cohen et al., 2008), with manual rebuilding using COOT (Emsley and 
Cowtan, 2004).  Crystallographic refinement was carried out using CNS (v. 1.1) 
(Brunger, 1998) followed by REFMAC, resulting in a final model with an Rfactor of ~19% 
and an Rfree of ~24% at 1.8 Å. 
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Figure A2.1. Above is the alignment of sequences from pg110, tp32, and MetQ. 
This alignment was generated using MUSTANG (Konagurthu et al, 2006). 
- 82 - 
 
 
 
 
 
 
Figure A2.2. Above is a picture of the crystals obtained from MetQ crystallization trials.  These long, 
rod-shaped crystals required seeding before the thickness was adequate for data collection. 
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Table A2.1: Summary of Secondary Structure for MetQ 
Secondary Structure Residue Range 
  
β1 32-38 
β2 60-66 
β3 83-87 
β4 103-110 
β5 115-117 
β6 132-136 
β7 178-182 
β8 198-201 
β9 218-220 
β10 229-234 
  
α1 41-57 
α2 70-78 
α3 89-99 
α4 139-152 
α5 184-192 
α6 203-209 
α7 241-250 
α8 253-263 
  
310 1 124-126 
310 2 167-169 
310 3 213-216 
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Table A2.2: Data Processing, Phasing and Refinement Statistics from MetQ 
 
Data processing  
Dataset Native 
Spacegroup C 2 2 2 1 
Unit Cell dimensions (Å) a= 59.89 
b= 87.76 
c= 113.10 
Wavelength (Å) 1 
Resolution (Å) 56.52-1.8  
Unique reflections 25217 
redundancy  5.0 (1.4) 
aCompleteness 90.0 (49.0) 
bRmerge .11 (0.49) 
  
Refinement  
Resolution (Å) 30-1.8  
Reflections used 23948 
Test reflections 1216 
cRWork (%) 19.0 
cRfree (%) 24.8 
Average B factor (Å2) 19.93 
Rmsd bond length (Å) 0.011 
Rmsd bond angle (°) 1.3 
  
Ramachandran (%)  
Most favored 91.6 
Allowed 8.4 
Disallowed 0 
aNumbers in parentheses refer to the highest resolution shell only. 
bRmerge=Σ|Ih-<I>h|/ΣIh, where <I>h is average intensity over symmetry equivalents. 
cR-factor=Σ|Fobs-Fcalc|/ΣFobs. 
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Chapter Four. Conclusions. 
Members of the methionine uptake transporter (MUT) system are of 
considerable biological interest for their role in nutrient import by bacteria.  As 
exogenous methionine is required for growth in certain bacterial pathogens, 
methionine transporters may be important for pharmaceutical development (Zhang, 
2003).  The regulatory functionality identified in the MetNI system provides an 
unexpected insight into the mechanism of these transporters and suggests additional 
possibilities for further studies.  Opportunities for further investigation of this ABC 
transporter system are numerous.  A higher-resolution crystal structure and a crystal 
structure of the MetNI transporter in complex with the MetQ binding protein would be 
quite interesting.  Additionally, further studies characterizing the regulatory domain of 
this transporter, as well as studies of this transporter in other conformations (with 
nucleotides) would provide a better understanding of the methionine uptake 
transporter system of E. coli. 
The field of research on ABC transporters is clearly growing.  The papers 
published in the last 2 years have provided greater insight into the structure and 
function of this fascinating family of proteins.  Specifically, the structures of intact 
complexes, such as the maltose, molybdate, and vitamin B12 systems, as well as the 
higher resolution HI1470/71 importer have led to a clearer understanding of the 
mechanism of transport and ATP hydrolysis, and have led to the creation of a more 
established framework to explain the process of ATP binding, binding-protein enabled 
substrate delivery, substrate binding locations within the translocation pathway, and 
now, with the structure of this methionine uptake transporter, an understanding of one 
possible mechanism of regulation.   
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Despite these advances, there are many questions about ABC transporters that 
remain unanswered.  Attempts to study issues concerning the binding sites within the 
translocation pathway and the affinity of these sites for a given substrate are underway.  
Similarly, a better picture of how ATP hydrolysis and substrate delivery interact and the 
sequence of events that lead up to the release of the substrate into the translocation 
pathway needs to be further clarified.  Regulatory mechanisms are poorly understood, 
and it would be interesting to further characterize multiple additional domains to 
understand how they are involved in regulation.  From a structural standpoint, 
structures of the same ABC transporter in distinct stages of the transport process, with 
nucleotides and substrates bound, are needed to understand the state of each 
transporter relative to the others within that transport process.  It is hoped that this 
field will be advanced through a combination of structural and biochemical analyses 
and this information can be applied to the study of medically relevant ABC transporters.  
This medical need stems from the actions of certain ABC exporters (either human or 
bacterial) that lead to various disease states, and it will be exciting to see this field 
contribute to therapeutics related to these conditions.  The field of research concerning 
ABC transporters has exploded with novel structures and mechanistic insights in the 
past few years, and faces an exciting future in both the scientific and medical fields. 
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